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ABSTRACT 
We hypothesized that global maternal nutrient restriction during early and mid-gestation 
followed by realimentation in pregnant beef cows would alter placental arterial vascular 
function. We tested changes in placental caruncular (CAR) and cotyledonary (COT) arterial 
sensitivity to bradykinin (BK), a potent vasodilator. Cows were randomly assigned to be nutrient 
restricted for 55 or 110 during early to mid pregnancy. On d 85, 140, and 254 cows were 
euthanized and CAR and COT arteries were isolated. Maternal nutrient restriction during early 
and mid-gestation allowed for placental compensation to overcome the loss of nutrients while 
realimentation returned placental arterial vosoactivity similar to control cows in response to BK. 
Further, CAR and COT placental arteries may respond to BK induced vasodilation through 
different pathways which is important when considering possible therapeutics for compromised 
pregnancies. 
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CHAPTER 1. LITERATURE REVIEW 
    Placental Function 
The placenta is a specialized and unique organ formed during pregnancy that carries on 
itself the burden of a successful pregnancy. From the time of conception until parturition, the 
placenta acts as the central organ that ensures optimum fetal growth and development. The 
establishment of maternal-fetal interactions during the earliest stages of embryonic development 
is of monumental importance because the two grow together, entwined in order to sustain and 
replenish life in the womb.  
 Several different types of mammalian placentas have been identified based on either their 
shape (Hamilton, Boyd and Mossman, 1972) and/or composition of their fetal membranes 
(Flexner and Gellhorn, 1943). Humans, have a highly invasive placenta classified as discoid and 
hemochorial, in which all maternal tissue has disappeared and maternal blood bathes the 
trophoblast (Thomas, 1997) whereas; a ruminant placenta is non-invasive and characterized as 
cotyledonary and epitheliochorial, in which all three maternal layers are intact (Senger, 2005). 
Regardless of the mammalian placental anatomy, all types ensure optimum health of the 
offspring. 
The primary function of the placenta is to regulate the fetal metabolic demands 
throughout gestation (Needham, 1934; Ramsey, 1982; Faber and Thornburg, 1983; Morris and 
Boyd, 1998; Reynolds and Redmer, 1995). In the cow, transplacental exchange occurs through 
specialized structures called the placentomes which forms an interface between the maternal and 
fetal systems. These can be visualized on the surface of uterine horns as convex, ovoid structures 
(King et al., 1979; Laven and Peters, 2001) ranging anywhere from 70-120 in number (Schlafer 
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et al., 2000), 2-3 cm thick and 10-12 cm long (Schlafer et al., 2000). Thus, the primary function 
of the placenta is to allow for the physiological exchange of respiratory gases, nutrients and 
elimination of fetal waste between the dam and the fetus (Meschia, 1983; Cross, 1998; Bell et al., 
1999; Reynolds and Redmer 1995, 2001). The placenta also functions to provide an 
immunological barrier against various pathogens and/or the maternal immune system, thereby 
establishing the uterus as an immunologically privileged site; hence, preventing the rejection of 
the conceptus (Soares, 1993; Cross, 1998; Bell et al., 1999; Bainbridge, 2000; Walker et al., 
2010). Additionally, the placenta also serves as an endocrine organ that secretes several 
hormones such as progesterone, estrogens (Hoffmann and Schuler, 2002), prolactin, and various 
growth factors (Anthony et al., 1995; Soares et al., 1998; Schlafer et al., 2000; Forsyth and 
Wallis, 2002; Gluckman and Pinal, 2003). These factors collectively, are crucial for establishing, 
nourishing and maintaining a viable and healthy fetus (Conley and Mason, 1990; Ogren and 
Talamantes, 1994; Solomon, 1994; Anthony et al., 1995).  
Besides the above mentioned functions, the placenta also plays a pivotal role in 
developmental programming. Any insults to the maternal system in utero have the capacity of 
altering bodily systems and processes including the placenta and placental function thus, 
producing life-long alterations in the postnatal life (Godfrey and Barker, 2000). This is especially 
relevant in intrauterine growth restriction (IUGR) which is often caused by maternal under-
nutrition during gestation that can lead to stunted placental and fetal growth and development 
(Barker, 1997). In fact, IUGR placentas in humans often display altered vasculogenesis (Krebs et 
al., 1996) and aberrant enzyme and hormone production (McMullen et al., 2005).  
As previously described, the placenta aids in nutrient transfer which is primarily achieved 
by regulating the utero-placental blood flow (Reynolds and Redmer, 1995) to the fetus. 
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Therefore, an abnormal placentation caused as the result of IUGR leads to a decrease in utero-
placental blood flow (Bell et al., 1999) resulting in fetal (Bell et al., 1999) and trophoblast 
(Myatt, 2006) hypoxemia, fetal hypoglycaemia, and pre-eclampsia (Myatt, 2006). In support of 
this concept, in a reduced utero-placental blood flow rodent model, Anderson et al. (2005, 2006) 
demonstrated a decrease in litter size, placental, and individual fetal weights. Moreover, the 
subsequent generations were programmed to exhibit persistent hypertension in their postnatal 
life.  
While it is evident that IUGR poses a significant threat to fetal growth and development, 
an optimal treatment remains problematic. Therefore, future studies investigating the effects of 
IUGR on placental function and placental vasculature are highly important.  
Placental Development 
Early Gestation 
Early gestation is a critical time for placental growth and development as it lays the 
foundation for the production of a viable and healthy offspring. The placenta begins to grow 
rapidly in order to support an exponential increase in fetal growth during late in gestation. 
Upon fertilization, on d 4 the bovine embryo enters the uterus and undergoes a series of 
cell division forming a morula by d 5 and a blastocyst consisting of a fluid filled cavity called the 
blastocoele by d 7 (Betteridge and Flechon, 1988). The outermost single layer of cells 
surrounding the blastocoele forms the trophoblast which gives rise to the bulk of the placenta 
(Schlafer et al., 2000).    
In the cattle, the placenta begins to form around d 18 to 19 of gestation when the 
trophoblast forms an intimate association with the uterine endometrium (Wooding and Morgan, 
 
 
4 
 
1993; Thie et al., 1998; Wathes and Wooding, 1980; MacLaren and Wildeman, 1995). This early 
attachment phase is a gradual process that occurs over several weeks (Melton et al., 1951) 
followed by the fusion of the trophoblast with the mesoderm to form the chorion.  
The blastocyst continues to grow accumulating more fluid in the coelom that pushes the 
specialized group of cells called the inner cell mass at one end of the cavity. This inner mass of 
cells gives rise to the endoderm that lines the yolk sac and eventually forms the fetus. Alongside 
endoderm, the mesoderm also vascularizes and extends further around the blastocyst. The 
embryo continues to grow and elongate and is soon surrounded by a fluid filled cavity called an 
amnion (Schlafer et al., 2000). By d 20 of gestation, a sac-like structure called an allantois 
(Betteridge and Flechon, 1988) extends from the hindgut of a fetus into the mesoderm. An 
allantois possesses blood vessels required for vascularization and together with the chorion it 
gives rise to the “chorioallantoic placenta” (Mossman, 1987; Schlafer et al., 2000; Wooding and 
Burton, 2008).    
In the bovine, before the establishment of maternal-fetal circulations, the fetus derives its 
energy from the endometrial histotroph (Melton et al., 1951; Stice et al., 1996; Thompson, 1997) 
which is soon replaced by specialized structures called the placentomes, which form an interface 
between the maternal and the fetal systems. Placentome development begins when the 
chorioallanotic membrane forms an intimate association with aglandular caruncular regions on a 
uterine wall. The placental membrane also contacts a uterine caruncle via finger like projections 
emerging from the chorion called the chorionic villi (Amoroso, 1952; Mossman, 1987), 
ultimately developing a cotyledon (Melton et al., 1951; Stice et al., 1996; Thompson, 1997). By 
d 30 of gestation, the caruncular (CAR) and the cotyledonary (COT) unit forms an intimate 
association giving rise to a placentome (Schlafer et al., 2000). Placentomes can be visualized as 
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slightly raised structures on the uterine surface by d 33 of gestation (King et al., 1979). On an 
average, 70 to 120 placentomes (Schlafer et al., 2000) could be found arranged in two dorsal and 
two ventral rows running lengthwise along the uterine horns. Placentomes function as the 
primary area of physiological exchange and enable the transfer of respiratory gases, nutrients and 
elimination of fetal waste between the dam and the fetus (Reynolds and Redmer, 1995, 2001).  
By d 42 until d 67 of gestation, the placental villous tree branches out extensively (King 
et al., 1979) to increase the surface area for transplacental exchange (Perry et al., 1999). This 
exchange occurs through the uterine and umbilical vascular beds which are responsible for the 
allocation of blood flow to the CAR and the COT portion of the placenta (Ramsey, 1982; 
Mossman, 1987).  
Mid-gestation 
Various animal models have demonstrated placental function as a characteristic of fetal 
weight, placental size and vascularity, and uterine and umbilical blood flows (Adair and 
Thelander, 1925; Ibsen, 1928; Warwick, 1928; Hammond, 1935; Mckeown and Record, 1953; 
Alexander, 1964; Oh et al., 1975; Wotton et al., 1977; Christenson and Prior, 1978; McDonald et 
al., 1979; Prior and Laster, 1979; Hard and Anderson, 1982; Myers et al., 1982; Caton, 1984; 
Ford et al., 1984; Reynolds et al., 1984; Johnson et al., 1985; Metcalfe et al., 1998; Ferrell, 1989; 
Ferrell and Reynolds, 1992; Vonnahme et al., 2001; Di Naro et al., 2003). Additionally, the fetal 
growth trajectory could also be affected by the fetal and maternal genotype, epigenetic, and 
environmental factors including nutritional stress and various diseases (Redmer et al., 2004). 
Needless to say, any alterations in these factors during gestation would have a direct impact on 
the placental function thus, influencing nutrient uptake by the gravid uterus (Bell and Ehrhardt, 
2002; Redmer et al., 2004).   
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Several mammalian studies have reported an exponential increase in the placental 
(Ferrell, 1989; Reynolds and Redmer, 1995; Bell et al., 1999) and fetal (Evans and Sack, 1973; 
Reynolds and Redmer, 1995) weights throughout gestation. In the ovine, maximum placental 
growth occurs early in gestation resulting in an increase in placentome weight by d 90 of 
gestation (Alexander, 1964; Stegeman, 1974). Following this, the placenta ceases to grow and 
the total placentome weight decreases by late gestation (Barcroft and Barron, 1946), despite a 
positive correlation between placental and fetal weight (Alexander, 1964). 
  In contrast with the ovine placental growth, in cattle and humans, the increase in 
placental and fetal weights occurs at different time points during gestation such that the overall 
increase in placental weight is far less than that of the absolute fetal weight (Ferrell et al., 1976; 
Ferrell and Ford, 1980; Reynolds et al., 1990; Reynolds and Redmer, 1995). This is due to the 
fact that maximal placental growth and differentiation occur during the first half of gestation 
(Ferrell, 1989; Reynolds and Redmer, 1995; Bell et al., 1999) with only limited growth in the last 
half to promote the dramatic fetal growth in the last trimester of gestation (Ibsen, 1928; 
Warwick, 1928; Hammond, 1935; Barcroft and Barron, 1946; Metcalfe et al., 1988; Ferrell, 
1989; Reynolds and Redmer, 1995). This is also accentuated by the fact that in the cow, from d 
100 to d 250 of gestation the CAR weight increased a little more than 2 fold although, the DNA 
concentration remained constant when compared with the COT. On the contrary, the COT DNA 
increased by 3 fold during the last two-thirds of gestation, indicative of COT hyperplasia 
occurring throughout gestation to keep pace with the ever increasing metabolic demands of the 
fetus (Reynolds et al., 1990; Reynolds and Redmer, 1995). Thus, the placenta undergoes rapid 
tissue remodelling from mid to late gestation which influences placental function and has the 
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capacity of altering blood flow to the CAR and COT sides of the placenta (Reynolds and 
Redmer, 1995; Reynolds et al., 2006).   
Late Gestation 
As described earlier, in ruminants, the first half of gestation marks maximal growth and 
differentiation of the placenta which is achieved by rapid proliferation of blood vessels within 
the placentome (Reynolds et al., 1992). The placental weight increases exponentially throughout 
gestation in the bovine, however the rate of increase slows significantly compared with the fetal 
weight during late gestation (Ferrell et al., 1976; Ferrell and Ford, 1980; Ferrell, 1989; Reynolds 
et al., 1990; Reynolds and Redmer, 1995); whereas, the placental mass ceases in the ovine 
(Barcroft, 1946; Wallace, 1948; Alexander, 1964). By late gestation, the primary function of the 
placenta is to support the exponential growth of the fetus during the last half of gestation (Ferrell, 
1989; Reynolds and Redmer, 1995; Metcalfe, 1998). This is not only achieved by an exponential 
increase in the uterine and umbilical blood flows (Ferrell and Ford, 1980; Morriss et al., 1980; 
Vorherr, 1982; Ford et al., 1984; Reynolds et al., 1985) but also, a uniform increase in the 
allocated blood flow to the CAR and COT placental vascular beds from mid to late gestation 
(Makowski et al., 1968; Rosenfeld et al., 1974; Meschia, 1983).  
By late gestation, in ewes and cattle, the magnitude of uterine blood flow is enhanced by 
3-20% (Rosenfeld et al., 1974; Reynolds et al., 1986; Reynolds and Redmer, 1995; Panarace et 
al., 2006) with 82% being exclusively directed to the caruncles in the ewes (Rosenfeld et al., 
1974; Rosenfeld and Fixler, 1977). Additionally, most of the increase in the gravid uterine blood 
flow is accompanied by a large decrease in uterine vascular resistance and an increase in arterial 
diameter due to vasodilation (Rosenfeld, 1984; Ford, 1995; Magness, 1998; Magness et al., 
2005). Similarly, there is an exponential rise in the umbilical blood flow in both, the bovine and 
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the ovine species, which keeps pace with the fetal growth (Rudolph and Hymann, 1970; 
Reynolds and Ferrell, 1987) and helps support 75-85% of the total fetal growth during the last 
0.4 months of gestation (Robinson et al., 1977; Prior and Laster, 1979).  
Therefore, an understanding of factors that impact the placental vascular development 
and function with relation to utero-placental blood flow would influence the nutritional and 
physiological status of the offspring both, in utero and in postnatal life.  
Developmental Programming and Influence of Maternal Nutrient Intake on Placental 
Vascular Development in Ruminants 
The concept of developmental programming explains that any insults or stressors to the 
maternal system while the fetus is in utero or during the neonatal period have the capacity of 
altering bodily systems and processes thus, producing life-long alterations in the postnatal life 
(Godfrey and Barker, 2000). Maternal suboptimal nutrition is one such stressor during pregnancy 
that is not only associated with a high risk of neonatal mortality and morbidity but can also 
program metabolic and reproductive changes in the offspring (Wallace, 1948; Wallace et al., 
1999a; Godfrey and Barker, 2000). In fact, livestock in the United States are often under a poor 
nutritional environment during pregnancy (Wu et al., 2006). This is mainly due to poor pasture 
conditions or an early breeding of peripubertal dams; thus, initiating a competition for nutrients 
between maternal body growth and fetal growth. 
There is increasing evidence that maternal under-nutrition during gestation in humans and 
livestock causes IUGR which can lead to stunted placental-fetal growth and development 
(Barker and Clark, 1997; Bell and Ehrhardt, 2002). In the United States, IUGR affects ~5% of 
the total human infants (Marsal, 2002). The incidence of IUGR resulting in low birth weight 
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infants ranges from 7-8% in the United States (NLM, 2002a, b; NVSR, 2004); 6% in Europe and 
the Western Pacific, and 24% in Southeast Asia (World Health Statistics, 2010). In fact, in 
livestock species including the cattle, nutritionally induced IUGR affects fetal nutritional and 
physiological status, negatively influencing animal’s body composition and reproductive 
performance in postnatal life (Wu et al., 2006; Funston et al., 2010). Additionally, the 
compromised fetal growth makes the offspring more susceptible to metabolic disorders, obesity, 
hypertension, insulin resistance, organ dysfunction, and cardiovascular diseases in their later life 
(Barker et al., 1993; Godfrey and Barker, 2000; Barker, 2004; Wu et al., 2006; Ford et al., 2007; 
Vonnahme et al., 2007; Dong, 2008; Funston et al., 2010). While, it is evident that IUGR poses a 
significant threat to the fetal growth and development, designing potential therapeutic strategies 
to overcome IUGR remains problematic.  
As described previously, maximal placental growth occurs during the first half of 
gestation, followed by the fetal growth during the last half of gestation (Ferrell et al., 1976; 
Ferrell and Ford, 1980; Reynolds et al., 1990; Reynolds and Redmer, 1995). This makes the fetal 
growth trajectory highly sensitive to the timing, duration, and severity of the maternal nutritional 
insult (Robinson et al., 1999). While there are quite a few studies elucidating the role of maternal 
suboptimum nutrition during pregnancy in humans and livestock (Meschia, 1983; Magness, 
1998; Konje et al., 2003; Reynolds et al., 2006; Vonnahme et al., 2007; Wallace et al., 2008); 
studies investigating the effects of maternal under-nutrition followed by realimentation on the 
bovine placental vasculature are limited. Further, the precise mechanisms mediating the effects 
of maternal nutrient restriction and/or realimentation on the bovine placental function and 
particularly on the CAR and COT arterial vasculature have not been revealed. Therefore, the 
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purpose of our research is to provide a better understanding of the bovine placental vascular 
remodelling during gestation which regulates the fetal growth and development.  
Early Gestation 
Maternal nutrient requirements might appear trivial during early gestation but, it plays a 
significant role in the placental-fetal development since, the earliest stages of embryonic 
development (Bishonga et al., 1996; Sugden, 2002; Waterland, 2004). Studies in ewes and 
rodents suggest that poor maternal nutrition at the time of conception leads to reduced number of 
cells in the inner cell mass (Robinson et al., 1994; Walker et al., 1996) which not only results in 
retarded fetal growth and organ function but also programs the offspring to exhibit hypertension 
in postnatal life (Kwong et al., 2000; Barker, 2001). Epidemiologic evidence in humans (Ravelli 
et al., 1988; Barker et al., 1993; Godfrey et al., 1996; Godfrey and Barker, 2000) and ewes 
(Whorwood et al., 2001) show that mothers who were nutritionally challenged during the first 
half of gestation were unable to supply nutrients to satisfy the fetal demands and hence, produced 
newborns that were proportionally longer and thinner than normal.  
Maternal under-nutrition has a significant impact on the placental growth in humans and 
ruminants. According to the study conducted by Lao and Wong (1996), the ratio of placental to 
birth weight was higher in babies whose mothers were lacking in adequate oxygen supply or 
nutrient resulting in placental enlargement at birth. Lumey (1998) also reported that 
undernourished human mothers during the first trimester delivered heavier and enlarged 
placentas at term. While, an enlarged placenta might be an adaptive response to compensate for 
the loss of nutrients during early gestation; there is increasing evidence that this catch up growth 
is in fact detrimental to the offspring making them more susceptible to metabolic disorders, 
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obesity, hypertension, insulin resistance, dislipidemia, organ dysfunction, and cardiovascular 
diseases in later life (Barker et al., 1993; Godfrey and Barker, 2000; Barker, 2004; Wu et al., 
2006; Ford et al., 2007; Vonnahme et al., 2007; Dong et al., 2008). Additionally, poor maternal 
nutrition during gestation has a capacity of producing epigenetic alterations, such that its adverse 
effects are not confined to one generation but, are tagged along with the subsequent generation to 
follow (Anderson et al., 2006; Ismail-Beigi et al., 2006; Wu et al., 2006). 
Similar to humans, compensatory placental growth was also observed in various models 
of undernourished ewes from early to mid-gestation (Owens et al., 1986; McCrabb et al., 1986, 
1991; Faichney and White, 1987). While, there are quite a few studies examining the role of 
maternal diet on fetal (Charlton and Johengen, 1985; Holst et al., 1986, 1992; Faichney and 
White, 1987; Bloomfield et al., 2000; Vonnahme et al., 2003; Scheaffer et al., 2004; Lemley et 
al., 2012) and placental (Charlton and Johengen, 1985; Faichney and White, 1987; McCrabb et 
al., 1991, 1992a, 1992b; Heasman et al, 1998; McMullen et al., 2005; Lekatz et al., 2010a, 
2010b; Lemley et al., 2012) growth in the ewes; Perry et al. (1999) have investigated the effects 
of restricting a particular dietary component on placental function in beef cattle. They reported 
an increase in the dry cotyledon weight at parturition in heifers who were fed a low protein diet 
during early (d 0 to d 99) gestation. Their finding supports the idea of placental-fetal adaptations 
occurring in early gestation to support the fetal nutritional demands in late gestation.   
Another study by Sullivan et al. (2009) examined the effects of maternal crude protein on 
the placental weights during early (d 1 to d 93) to mid gestation (d 93 to d 180) in beef heifers. A 
specific breed of beef heifers receiving low dietary protein (75%) during early gestation had an 
increase in placental weight compared with the high protein (250%) receiving group. However 
these findings were highly influenced by the maternal genotype as a decrease in placental weight 
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was observed when the same low protein concentration (75%) diet was fed to a different breed of 
beef heifers compared with the controls. Furthermore, no differences were observed in COT 
numbers, COT weight, COT surface area, and placental efficiency.  
Comparable studies conducted by Vonnahme et al. (2007) and Zhu et al. (2007) 
investigated the effects of 50% global maternal nutrient restriction early in gestation (d 30 to d 
125) on the bovine placental vasculature. Vonnahme et al. (2007) observed an increase in the 
placental angiogenic factors while no differences were reported in the capillary vascularity of the 
CAR and COT tissues. Further, the fetal and placentome weights were also reduced at the end of 
nutrient restriction period, on d 125 of gestation. On the contrary, Zhu et al. (2007) did not notice 
any differences in the fetal weight although; the placentome weight was reduced in the nutrient 
restricted cows when compared with the control cows. An increase in the COT arteriolar 
vascularity was also observed which perhaps enhanced the placental efficiency in the nutrient 
restricted cows (Zhu et al., 2007). The authors interpreted that these variations arose as a result 
of the distinct blood vessel types (capillaries vs arterioles) measured in the two studies.   
While there are slight differences in the results, these studies strongly indicate that 
alterations in placental function might be a result of maternal under-nutrition during early 
gestation. Therefore, future studies elucidating the role of maternal under-nutrition during early 
gestation on placental function in relation with the placental vascular architecture within the 
cattle are imperative.   
Mid-gestation 
Several mammalian studies have reported an exponential increase in the placental 
(Ferrell, 1989; Reynolds and Redmer, 1995; Bell et al., 1999) and fetal (Evans and Sack, 1973; 
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Reynolds and Redmer, 1995) weights throughout gestation. As described previously, in the 
sheep, maximum placental growth occurs early until d 90 of gestation (Alexander, 1964; 
Stegeman, 1974), thereafter the placenta ceases to grow in mass (Barcroft and Barron, 1946) 
despite a positive correlation between placental and fetal weight (Alexander, 1964). Unlike in the 
ovine species, mid-gestation in the bovine is marked by maximal placental growth and 
differentiation (Barcroft and Barron, 1946; Metcalfe et al., 1988; Ferrell, 1989; Reynolds and 
Redmer, 1995; Bell et al., 1999) which continues to keep pace with increasing fetal demands 
throughout gestation.  
Maternal nutrition during this crucial period of placental establishment has a significant 
impact on the fetal growth (Wallace, 1948; Wallace et al., 1999a; Godfrey and Barker, 2000). 
Numerous animal models investigating the effects of maternal diet in the ewes and cows have 
obtained variable results on the placental and fetal growth during mid-gestation in both species.   
Clarke et al. (1998) reported a lower placental weight in ewes fed 50-60% of energy 
requirements compared with controls from d 30 to d 80 in gestation. Vonnahme et al. (2003) 
observed a marked reduction in fetal weight on d 78 of gestation when ewes were restricted to 
50% of their dietary intake requirements compared with the control ewes receiving 100% of their 
energy requirements from d 28 to d 80 of gestation. A similar study conducted by Redmer et al. 
(2004) also demonstrated lower fetal weights and increased placental vascularity with no 
alterations in the placentome weight in ewes fed 60% global nutrient intake compared with 
control ewes fed 100% of energy requirements from d 50 to d 130 of gestation.  
In the bovine, Perry et al. (1999) demonstrated that a period of protein restriction during 
early gestation (d 0 to d 99) followed by a high protein diet in mid-gestation (d 100 to d 198 of 
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gestation) led to enhanced trophectoderm volume density and enlarged placentas at term due to 
the greater development of microvilli. These researchers suggested that larger placentas would 
create an optimal design for absorption of nutrients to help support the fetal growth during late 
gestation.  
Looking particularly at the realimentation studies in the bovine, documented responses by 
Vonnahme et al. (2007) and Zhu et al. (2007) show that a period of nutrient restriction (d 30 to d 
125 of gestation) followed by realimentation (d 125 to d 250 of gestation) produce contrasting 
results in the CAR and COT placental tissues. Upon realimentation (d 125 to d 250 of gestation), 
in the under-nourished cows, the COT capillary area density, COT capillary surface density and 
COT capillary number density was markedly reduced whereas, the CAR capillary surface 
density was increased compared with the control cows. Additionally, the total placentome weight 
and the COT weight continued to be lower throughout gestation, even after realimentation (Zhu 
et al., 2007).  
On the contrary, in the ewe, placental growth was enhanced upon realimentation in ewes 
when preceded by a period of nutrient restriction from early to mid-gestation (Foote et al., 1958; 
Robinson et al., 1995; Heasman et al., 1999; McMullen et al., 2005). A similar study by DeBarro 
et al. (1992) yielded similar results where placental hypertrophy was enhanced in well-nourished 
ewes subjected to nutrient restriction during mid-gestation; however, a period of poor nutrition 
during mid-gestation in formerly undernourished ewes produced detrimental effects on placental 
and fetal growth. These findings led the researchers to believe that the placental compensation 
might be directly related with the maternal nutrient store at the time of conception (McCrabb et 
al., 1992; Robinson et al., 1994).  
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Overall these studies indicate that maternal nutrition during mid-pregnancy significantly 
influences the vascular function of the placenta which has the capacity of altering fetal growth. 
There are only a few studies examining the role of realimentation on the placental vascularity in 
the cow hence, any conclusions are tentative and future studies are warranted. Furthermore, the 
differences in the placental growth and vascularity in the ovine and the bovine species is quite 
evident; thus, it is imperative that the two species are studied separately and compared with 
caution.   
Late Gestation 
By late gestation, the primary function of the placenta is to support the exponential 
growth of the fetus during the last half of gestation (Metcalfe, 1988; Ferrell, 1989; Reynolds and 
Redmer, 1995). Several models of underfed ewes during late gestation have found to hinder the 
fetal growth trajectory (Mellor, 1983; Robinson, 1983; Vincent et al., 1985; Parr et al., 1986) and 
transplacental exchanges. Nutrient restricted underfed adolescent (Luther et al., 2005) ewes 
experienced a 17% reduction in fetal weight and a 20% reduction in capillary area density. 
Likewise, adult ewes that underwent severe nutrient restriction during late gestation (d 120 to d 
144 of gestation) had a marked decrease in fetal weight (17%) and uterine blood flow (20-33%) 
(Chandler et al., 1985; Leury et al., 1990; Newnham et al., 1991; Kelly, 1992; Arnold et al., 
2001).  
In humans, the Dutch Hunger Winter is a classic example of placental remodelling 
occurring as a result of maternal under-nutrition during different stages in gestation. A period of 
maternal nutrient restriction during early gestation resulted in compensatory placental growth; 
however, the same during late gestation resulted in lighter placentas and low birth weight infants 
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at parturition (Lumey et al., 1998). As previously described, the placenta aids in nutrient transfer 
which is primarily achieved by regulating the utero-placental blood flow (Reynolds and Redmer, 
1995) to the fetus. An abnormal placentation in humans resulting from maternal under-nutrition 
during the last trimester causes IUGR leading to a decrease in utero-placental blood flow, fetal 
hypoxaemia, fetal hypoglycaemia, and organ dysfunction (Pardi et al., 1993; Marconi et al., 
1996; Ferrazzi et al., 2000).   
Langley-Evans et al. (1996a) constructed a rodent model to investigate the effects of 
protein restriction during gestation on fetal and placental development. Rats were either control 
fed receiving 14% casein or protein restricted receiving only 9% casein in their diet. These 
researchers observed an increase in placental (d 14 and d 20 of gestation) and fetal weight (d 14, 
d 18 and d 20 of gestation) in the restricted fetuses; however fetal weight and organ growth were 
significantly reduced at term (d 22 of gestation) indicating a difference in the restricted and the 
control fetal growth rate patterns during the last two days of gestation. Additionally, the 
restricted pups by week four were programmed to exhibit hypertension in their postnatal life. 
Desai et al. (2005), Belkacemi et al. (2009), and Karadag et al. (2009) choose to study the 
impact of 50% nutrient restriction during late gestation in rats. A restricted nutrient supply led to 
a decrease in placental (Belkacemi et al., 2009) and fetal (Desai et al., 2005; Belkacemi et al., 
2009; Karadag et al., 2009) weights. Furthermore, the researchers also noted an increase in the 
incidence of placental apoptosis at the site of placental labyrinth in the under fed rats (Belkacemi 
et al., 2009). Akohas et al. (1984) also showed a 17% and 26% reduction in mean fetal and 
placental weight in rats receiving 50% of energy requirements from d 5 to d 21 in gestation, 
compared with ad libitum fed control rats. Moreover, the placental insufficiency in the nutrient 
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restricted rats was due to increased vascular resistance leading to a 30% reduction (Akohas et al., 
1983) in transplacental exchange.  
Studies investigating the impacts of maternal under-nutrition and particularly 
realimentation on the bovine placental vasculature are quite limited. As mentioned previously, 
Vonnahme et al. (2007) observed a marked decrease in COT capillary area density, COT 
capillary surface density, and COT capillary number density upon realimentation in 
undernourished cows from d 125 to d 250 of gestation compared with the control cows. 
However, Zhu et al. (2007) observed no such differences in the COT arterioles measured. 
Vonnahme et al. (2007) and Zhu et al. (2007) both reported an increase in the CAR capillary 
surface density and CAR arteriolar density in the restricted cows than the control cows. The 
researchers interpreted, that the observed increase in the CAR tissue led to enhanced placental 
efficiency in the nutrient restricted cows compared with the control cows. 
Overall, these studies strongly suggest that the fetal growth and development which 
maximally occurs in the last trimester of pregnancy is highly sensitive to the maternal stores of 
energy and any detrimental effects of maternal nutrition would lead to stunted placental-fetal 
development in any species. Furthermore, there is a lack of literature focusing on the impacts of 
maternal diet particularly on the bovine placental vasculature. Therefore, more studies are 
imperative.  
Regulators of Blood Flow and Placental Vascular Function 
Pregnancy in all mammals is energetically costly and marks a 20-50% increase in the 
maternal metabolic rate (Brody, 1938; Ferrell et al., 1976; Ferrell and Jenkins, 1985; Robson et 
al., 1989; Stock and Metcalfe, 1994). A large increase in the metabolic rate primarily supports 
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the dramatic alterations in the maternal cardiovascular system and the utero-placental vascular 
bed (Rosenfeld and Fixler, 1977; Reynolds and Redmer, 1995; Magness, 1998) ensuring 
optimum fetal growth and development (Reynolds and Redmer, 1995; Reynolds et al., 2010). 
During a normal pregnancy, uterine blood flow continues to rise throughout gestation. This is 
primarily achieved by a reduction in systemic vascular resistance and an increase in the cardiac 
output through an increase in heart rate and stroke volume (Rovinsky and Jaffin, 1966; Walters 
et al., 1966). Thus, for the systemic blood pressure to remain constant throughout pregnancy, the 
cardiac output increases and the total peripheral resistance decreases (Ford, 1982; Rosenfeld, 
1984; Magness and Zheng, 1996; Magness, 1998). In fact, placental vascular insufficiency and 
elevated vascular resistance may lead to embryonic loss and impaired nutrient delivery to the 
fetus (Reynolds and Redmer, 1995, 2001; Reynolds et al., 2010). 
During pregnancy, the placenta undergoes a variety of physiological changes to adapt to 
the various environmental stressors to drive fetal programming by regulating utero-placental 
blood flows to the fetus. This has been established by various models of placental insufficiency 
in sheep, pigs, and humans where uterine and umbilical blood flows were reduced (Meschia, 
1983; Magness, 1998; Konje et al., 2003; Reynolds et al., 2006; Vonnahme et al., 2007; Wallace 
et al., 2008). There is increasing evidence that physiological alterations in the placental function 
and placental vasculature are controlled by several vasodilator and vasoconstrictor systems 
(Wang and Zhao, 2010). Additionally, the placental vascular tone could also be modulated by 
changes in receptor and gene expression of various angiogenic factors (Redmer et al., 2005; 
Reynolds et al., 2005 a, b, 2006; Luther et al., 2007; Vonnahme et al., 2007; Luther et al., 2008; 
Borowicz et al., 2009a).  
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Vasodilator pathways are imperative for maintaining optimum blood flow to the fetus. 
One fascinating example is the complex kallikrien kinin system (KKS) which is an integral part 
of the extensive vasodilatory network and is known for its interactions with other physiologic 
pathways such as the renin-angiotensin and complement pathways. The complex KKS produces 
a vasoactive kinin called bradykinin (BK) which lies at the center of this system. This portion of 
this review will specifically focus on BK production, its role in reproduction, and its mechanism 
of action for mediating vasorelaxation.  
Kallikrein-kinin System 
The kallikrein-kinin is a highly complex system where kallikrein represents a group of 
serine proteases which function to produce vasoactive peptides, the kinins, by acting on the 
endogenous substrates called kininogens (Müller-Esterl, 1989). Kallikrein has long been 
identified for its two different forms namely, the plasma and the tissue (Fiedler, 1979; Movat, 
1979) kallikreins; which differ in several measures including the types of kinins liberated 
(Webster and Pierce, 1960; Webster, 1970; Fritz et al., 1977; Bhoola et al., 1979; Schachter, 
1980; Fuller and Funder, 1986; Kalpan and Silverberg, 1987) which can result in either 
vasoconstriction or vasodilation. The released kinins are further classified into two types, based 
on the type of kininogen [high molecular weight kininogen (HK) and low molecular weight 
kininogen (LK)] (Jacobsen, 1966) stimulating its production. The HK stimulates the production 
of BK while the LK produces kallidin (KD) when acted upon by the plasma and the tissue 
kallikerins, respectively.  
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Plasma Kallikrein 
Plasma kallikrein, or the Fletcher Factor, is recognized for its pivotal role in the intrinsic 
coagulation pathway and formation of BK. It is secreted in an inactive form called the plasma 
prekallikrein (Mandle et al., 1976; Reddigari and Kaplan, 1988; Bhoola et al., 1992); a single 
chain glycoprotein and a single gene product synthesized in the liver by hepatocytes (Asakai et 
al., 1987; Yu et al., 1998). Plasma prekallikrein cleaves the bound HK (Mandle et al., 1976; 
Reddigari and Kaplan, 1988; Bhoola et al., 1992) to liberate BK through a complex mechanism.  
 Factor XII, or Hageman factor, is the initiating protein and an essential part of the 
intrinsic coagulation pathway which gets activated upon contact with polyanionic surfaces or 
damaged blood vessels resulting in an autocatalytic cleavage of factor XII to form factor XIIa. 
Plasma prekallikrein and factor XI both complexed with HK (Mandle et al., 1976; Thompson et 
al., 1977; Wiggins et al., 1977; Sugo et al., 1980; Bhoola et al., 1992) are the two major 
substrates for factor XIIa. These complexes achieve a proper conformation by binding to the 
attachment sites on the HK domains resulting in cleavage of factor XI and prekallikrein to factor 
XIa and plasma kallikrein. While formation of factor XIa results in the continuation of the 
coagulation pathway (Ratnoff et al., 1961), plasma kallikrein exclusively cleaves HK to produce 
BK (Mori and Nagasawa, 1981; Kalpan and Silverberg, 1987). In addition to the above 
mentioned mechanism, BK is also produced by the binding of HK to endothelial cells. Following 
the binding, prekallikrein is readily cleaved to kallikrein resulting in the liberation of BK from 
HK (Nishikawa et al., 1992; Motta et al., 1998; Zhao et al., 2001).  
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Tissue Kallikrein (TK) 
 As the name suggests, tissue kallikreins are tissue specific enzymes encoded by a 
multigene family (Clements, 1989; Diamandis et al., 2000) with variable gene expressions in 
different tissue (Mason et al., 1983; Ashley and Mcdonald, 1985; Baker and Shine, 1985; 
Richards et al., 1989; Wines et al., 1989; Qin et al., 1991). The enzyme is expressed in several 
different tissues including lungs, kidney, intestine, brain, pancreas, spleen, adrenals, blood 
vessels, salivary and sweat glands (Bhoola et al., 1992; Mahabeer and Bhoola, 2000) with the 
number of genes forming the kallikrein family being highly variable amongst the different 
mammalian species (Mahabeer and Bhoola, 2000). However, only one gene encoding for the true 
form of tissue kallikrein (TK) involved in the release of vasopeptides has been identified. The 
enzyme was first isolated from porcine pancreatic kallikrein (Fiedler et al., 1976; Tschesche et 
al., 1979) and synthesized as prokallikrein (Kamada, 1990). The TK primarily functions to 
liberate a one residue longer kinin, Lys-BK or KD from its preferred substrate, the LK. Unlike 
the plasma kallikrein which exclusively cleaves HK to release BK, TK also has the capacity of 
producing BK by cleaving HK (Mahabeer and Bhoola, 2000).  
Bradykinin: Its Receptors and Role during Gestation 
 The BK, a nonapeptide (H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH), is a stimulator 
of vascular permeability (Bhoola et al., 1992) and a potent vasodilator which enhances blood 
flow to the uterus during estrous cycle (Resnik et al., 1976) and the utero-placenta during 
gestation (Albertini et al., 1980). Corthorn et al. (1997) have previously demonstrated an 
increase in TK expression in ovariectomized rats receiving subcutaneous doses of estrogen 
explaining the elevation observed in TK mRNA expression during proestrous stage of the estrous 
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cycle in rat (Corthorn and Valdés, 1994), and early pregnancy (Valdés et al., 1993). Since, one of 
the cleaved products of TK is BK and throughout gestation the developing placenta augments its 
production of estrogen becoming the major source of the steroid; it is essential to investigate the 
role of BK on placental vascular function during gestation which may contribute towards 
enhanced blood flow to the gravid uterus. In addition, BK also promotes angiogenesis, vascular 
permeability (Valdéz and Corthorn, 2011), and exerts its physiological effects on the 
cardiovascular system by acting on the vascular endothelium (Hong, 1980; Cocks et al., 1985; 
Palmer et al., 1987; Gryglewski et al., 1986; Mombouli et al., 1996; Bas et al., 2007).    
The BK acts on the two cell surface G-protein coupled receptors, the BK1 receptor 
(BK1R) and the BK2 receptor (BK2R) (Bhoola et al., 1992; Leeb-Lundberg et al., 2005), the 
latter being the predominant receptor type (Bas et al., 2007). The kinin receptors share 36% 
sequence homology (Menke et al., 1994) and are members of the seven transmembrane family 
(Hess et al., 1992).   
The locally produced kinin, BK is an autocoid which is readily cleaved by kininase I 
hence, making the accurate measurements of the peptide quite difficult. The action of kininase I 
on BK yields des-Arg-BK (Kurachi et al., 1977; Kaplan 2002) which selectively stimulates the 
BK1R, expressed as a result of chronic injury and inflammation (Regoli et al., 1980; Chai et al., 
1996; Kaplan, 2002). On the contrary, the BK2R is expressed in various tissues and organs 
including the endothelial and vascular smooth muscle cells (Bhoola et al., 1992; Marceau et al., 
1998; Christiansen et al., 2002; Marceau and Regoli, 2004; Souza et al., 2004; Moreau et al., 
2005). Valdés et al. (2001) successfully localized the BK2R and TK in luminal and glandular 
epithelium, decidual cells, trophoblast invading arteries, endothelium and vascular, and 
myometrial smooth muscle in a human uterus. Since, these sites constitute the fetomaternal 
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interface, intervene in embryo attachment, implantation, placentation, and help in maintenance of 
placental blood flow and parturition; it establishes the investigation of KKS pathway particularly 
BK of monumental importance which highly likely aids these processes through vasodilation, 
increased vasopermeability, and stimulation of cell proliferation. The BK2R further promotes the 
release of endothelium derived vasodilatory mediators: nitric oxide (NO) (Furchgott and 
Zawadzki, 1980; Ignarro et al., 1981,1989; Moncada et al., 1991; Furchgott, 1995; Bian and 
Murad, 2003; Tanaka et al., 2004), prostacyclin (PGI2) (Moncada et al., 1976; Coleman et al., 
1994; Wise and Jones, 1996; Narumiya et al., 1999; Tanaka et al., 2004) and endothelium 
derived hyperpolarizing factors (EDHF(s)) (Nagao and Vanhoutte, 1993; McGuire et al., 2001; 
Busse et al., 2002; Suzuki, 2003; Triggle et al., 2003) for mediating vasorelaxation (Magness et 
al., 1993; Gainer et al., 1998). There is increasing evidence elucidating the important 
contributions of NO, PGI2, and EDHF(s) in vasodilation since their role is up regulated as a 
result of an increase in endothelium stimulation during pregnancy (Poston et al., 1995; Gerber et 
al., 1998; Kenny et al., 2002; Bird et al., 2003).  
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Figure 1.1. A simplified illustration of the kallikrein-kinin system (KKS). The KKS pathway 
involves the cleavage of kininogen by enzyme kallikrein for the production of a vasoactive kinin, 
bradykinin, a potent vasodilator. Bradykinin acts on kinin receptors on endothelial cells to 
liberate endothelial-derived hyperpolarizing factors (EDHF(s)), prostacyclin (PGI2), and nitric 
oxide (NO) for mediating vasorelaxation.   
Nitric Oxide (NO) 
The binding of BK to the BK2R triggers a cascade of events leading to vasodilation by 
the release of nitric oxide (NO) from the endothelial cells. Previously recognized as the 
endothelium derived relaxing factor (Cherry et al., 1982), NO is a free radical liberated as a 
Kininogen 
Kallikrein 
Bradykinin 
EDHF(s) PGI2 NO 
Vasodilation 
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result of simulation of the Ca
2+ 
dependent endothelial NO synthase (eNOS). The released NO 
diffuses from endothelial to smooth muscle cells activating soluble guanylate cyclase (sGC) 
causing an increase in the cGMP levels (Furchgott et al., 1981; Ignarro and Kadowitz, 1985; 
Ignarro, 1989). The elevated level of cGMP functions to activate protein kinase which in turn 
phosphorylates several proteins decreasing intracellular Ca
2+ 
sensitivity; hence, stimulating 
dephosphorylation of myosin and producing vasorelaxation (Waldman and Murad, 1987; 
Carvajal et al., 2000). The vasodilatory effects of NO are blocked upon treatment with N(nitro)- 
L-arginine (NLA) (Pfeiffer et al., 1996). 
Endothelium Derived Hyperpolarizing Factors (EDHF(s)) 
The endothelium derived hyperpolarizing factors or (EDHF(s)) are representative of a 
diverse group of chemical compounds comprising of  L-citrulline, K
+
 ion, H2O2, anandamide, 
and epoxyeicosatrienoic acids (Tanaka et al., 2004). These play a pivotal role in controlling 
resistance at the level of microvessels thereby influencing the systemic blood pressure (Suzuki et 
al., 1998; McGuire et al., 2001; Busse et al., 2002). Upon BK stimulation, one of the proposed 
mechanisms for mediating vasorelaxation, predominantly in the bovine coronary artery (Gauthier 
et al., 2005) involves the endothelium dependent hyperpolarization of vascular smooth cells 
through activation of the large conductance Ca
2+ 
activated K
+
 channels or the BKCa channels 
(Popp et al., 1996; Gauthier et al., 2005; Campbell and Falck, 2007; Campbell and Fleming, 
2010). An increase in the intracellular Ca
2+ 
level and membrane depolarization acts as a trigger 
for BKCa channels which when activated promote the efflux of K
+
 ions from the cells causing 
membrane hyperpolarization (Nelson and Quayle, 1995; Jackson, 2000, 2005) and 
vasorelaxation. The vasodilatory effects of BKCa channels are attenuated upon treatment with 
iberiotoxin (IbTX) (Galvez et al., 1990).  
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Prostacyclins (PGI2) 
Prostacyclin (PGI2) is an eicosanoid and a predominant metabolite of arachidonic acid 
released from the endothelial cells (Moncada et al., 1976, 1979) mediating vasodilation in 
vascular smooth muscle and inhibiting platelet aggregation (Robbins and Cotran, 1979). Due to 
its short half life various stable analogues of PGI2 have been established to treat diseases such as 
pulmonary hypertension (Christman et al., 1992), hypoxia (Frisbee, 2001) and several 
cardiovascular diseases (Fink et al., 1999). Its active role in promoting relaxation has been 
established in human pulmonary artery and vein (Haye-Legrand et al., 1987; Walch et al., 1999), 
bovine coronary artery (Vegesna and Diamond, 1986), rabbit celiac, mesenteric and renal 
arteries (Ercan and Turkar, 1985), guinea pig aorta (Clapp et al., 1998; Ozaki et al., 1996) and 
dog cerebral, coronary, mesenteric, renal, and femoral arteries (Akiba et al., 1986). Once 
liberated from the endothelial cells by the action of the enzyme prostacyclin synthase, PGI2 binds 
to IP receptor; belonging to the family of G-protein coupled receptors (Coleman et al., 1994; 
Narumiya et al., 1999; Wise and Jones 1996) and promotes paracrine signalling activating 
adenylyl cyclase and causing an increase in cAMP levels (Coleman et al., 1994; Narumiya et al., 
1999; Wise and Jones 1996) leading to vasorelaxation. The elevated levels of cAMP also 
activates protein kinase A, leading to myosin relaxation and membrane hyperpolarization 
(Parkington et al., 1995; Corriu et al., 2001) ensuring vasodilation of vascular smooth muscle 
cells. The vasodilatory effects of PGI2 are attenuated upon treatment with indomethacin (INDO) 
(Hart and Boardman, 1963). 
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Statement of the Problem 
The concept of developmental programming explains that any insults or stressors to the 
maternal system in utero or during the neonatal period have the capacity of altering bodily 
systems and processes thus, producing life-long alterations in the postnatal life (Godfrey and 
Barker, 2000). Maternal suboptimal nutrition is one such stressor during pregnancy that is not 
only associated with a high risk of neonatal mortality and morbidity but can also program 
metabolic and reproductive changes in the offspring (Wallace, 1948; Wallace et al., 1999a; 
Godfrey and Barker, 2000). In fact, livestock in the United States are often under a poor 
nutritional environment during pregnancy (Wu et al., 2006). There is increasing evidence that 
maternal under-nutrition during gestation in humans and livestock causes IUGR which can lead 
to stunted placental-fetal growth and development (Barker and Clark, 1997; Bell and Ehrhardt, 
2002). While, it is evident that IUGR poses a significant threat to the fetal growth and 
development, designing potential therapeutic strategies to overcome IUGR remains problematic.  
The placenta aids in nutrient transfer which is primarily achieved by regulating the utero-
placental blood flows (Reynolds and Redmer, 1995) to the fetus. Therefore, an abnormal 
placentation caused as the result of IUGR leads to a decrease in utero-placental blood flows 
(Bell, 1999; Hay Jr. et al., 1999) resulting in fetal (Bell, 1999; Hay Jr. et al., 1999) and 
trophoblast (Myatt, 2006) hypoxaemia, fetal hypoglycaemia, and pre-eclampsia (Myatt, 2006).  
Since in the bovine, maximal placental growth occurs during the first half of gestation, followed 
by the fetal growth during the last half of gestation (Ferrell et al., 1976; Ferrell and Ford, 1980; 
Reynolds et al., 1990; Reynolds and Redmer, 1995), this makes the fetal growth trajectory highly 
sensitive to the timing, duration, and severity of the maternal nutritional insult (Robinson et al., 
1999). 
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There are several studies examining the role of maternal diet on fetal (Charlton and 
Johengen, 1985; Holst et al., 1986, 1992; Faichney and White, 1987; Bloomfield et al., 2000; 
Vonnahme et al., 2003; Scheaffer et al., 2004; Redmer, 2004; Lemley et al., 2012) and placental 
(Charlton and Johengen, 1985; Faichney and White, 1987; McCrabb et al., 1991, 1992a, 1992b; 
Heasman et al, 1998; Redmer, 2004; McMullen et al., 2005) growth in the ewes; however, due to 
the evident differences in the placental growth and vascularity in the two species, it is imperative 
that the ovine and the bovine species are studied separately and compared with caution. 
While, there are a few studies elucidating the role of maternal suboptimum nutrition 
during pregnancy in bovine; studies investigating the effects of maternal under-nutrition 
followed by realimentation on the bovine placental vasculature are limited (Perry et at., 1999; 
Vonnahme et al., 2007; Zhu et al., 2007). Furthermore, the precise mechanisms mediating the 
effects of maternal nutrient restriction and/or realimentation on the bovine placental function and 
particularly on the caruncular and cotyledonary arterial vasculature have not been revealed. 
Therefore, the purpose of our research is to provide a better understanding of the bovine 
placental vascular remodeling during gestation which regulates the fetal growth and 
development.  
We hypothesize that global maternal nutrient restriction during early and mid-gestation 
and restriction followed by realimentation in pregnant beef cows would alter placental arterial 
vascular function due to changes in placental arterial sensitivity to bradykinin. Further, we also 
hypothesize that placental arterial vasodilation is mediated at least partly through the bradykinin 
2 receptor and that global maternal nutrient restriction and realimentation may impact the 
pathways mediating bradykinin induced vasodilation in the placental arteries.  
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CHAPTER 2. INFLUENCE OF MATERNAL NUTRIENT RESTRICTION DURING 
EARLY PREGNANCY ON PLACENTAL VASCULAR FUNCTION IN PREGNANT 
BEEF COWS 
Abstract 
We hypothesize that maternal nutrient restriction during early gestation would alter the 
caruncular (CAR) and cotyledonary (COT) placental artery sensitivity to bradykinin (BK) 
induced relaxation. Further, we hypothesized the placental arterial vasodilation is mediated at 
least partly through the bradykinin 2 receptor (BK2R) and its pathways which may be impacted 
by the maternal diet. To examine the effects of maternal nutrient restriction on CAR and COT 
artery vasoactivity during early gestation, multiparous beef cows were randomly assigned to 
either 100% (C; n = 6) or 60% NRC requirements (R; n = 4) on d 30 of gestation. At d 85 of 
gestation cows were euthanized and arteries that terminated into the maternal (CAR artery) and 
fetal portions (COT artery) of the placentome were dissected to be used for in vitro 
vasoreactivity assays and mRNA expression. The endothelium-intact CAR arterial rings were 
loaded in an organ bath chamber and contracted with NE (10
-6
 M) and the concentration 
response curve (CRC) to BK was obtained. In addition, a BK CRC was obtained for rings which 
were incubated for 30 min with inhibitors to: 1) BK2R, icatibant acetate (HOE 140; 10
-6 
M); 2) 
large conductance Ca
2+ 
activated K
+
 channels, iberiotoxin (IbTX; 10
-7 
M); 3) endogenous nitric 
oxide synthase, N(nitro)-L-arginine, (NLA; 10
-5
 M); and 4) prostacyclins (PGI2), indomethacin 
(INDO; 10
-5
 M). Additionally, endothelium-intact COT arterial rings were contracted with 
U46619 (10
-6
 M) and the effect of BK and the above mentioned inhibitors were studied with the 
exception of PGI2. The CAR arterial rings with no inhibitor (NI) were influenced by the maternal 
diet and arteries from the R cows were more sensitive (P < 0.0001) to BK induced relaxation 
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compared with the C cows. An overall effect of maternal nutrition was observed which blocked 
(P < 0.0001) BK mediated vasodilation in the C and R arteries incubated with HOE 140. In the 
CAR placental arteries, the BK dose response curves had a significant treatment by dose 
interaction in the presence of IbTX (P ≤ 0.04) and NLA (P ≤ 0.04) which blocked relaxation in 
the C and the R arteries. An effect of maternal diet was observed in the presence of INDO which 
inhibited relaxation (P < 0.0001) in the C and the R arteries. Our findings indicate that the 
downstream pathways activated by BK are important for vasodilation in the CAR placental 
arteries. The COT arteries with NI had a significant treatment by dose interaction and arteries 
from R cows were more sensitive (P = 0.04) to the BK induced relaxation compared with C 
cows. A significant treatment by dose interaction (P < 0.0001) was observed in C cows in the 
presence of HOE 140 while an effect of diet (P = 0.004) was observed in the R cows which 
blocked relaxation in the COT arteries. The C arteries were more sensitive (P = 0.003) to BK 
induced relaxation in the presence of IbTX while no effect was observed in the R arteries. In the 
COT placental artery, a significant treatment by dose interaction was observed in the presence of 
NLA and relaxation was completely abolished (P < 0.0001) across treatments. The mRNA 
expression of BK2R was not altered (P ≥ 0.51) by the maternal diet during early gestation. 
Results from this study indicate that maternal nutrient restriction does not negatively impact fetal 
or placental growth and it appears to alter placental vascular function, which could alter nutrient 
availability to the conceptus. 
 Key words: bradykinin, cow, placenta, vascular function 
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Introduction 
Maternal nutrient requirements might appear trivial during early gestation but it plays a 
significant role in the placental-fetal development since the earliest stages of embryonic 
development (Bishonga et al., 1996; Sugden, 2002; Waterland, 2004). Studies in ewes and 
rodents suggest that poor maternal nutrition at the time of conception leads to reduced number of 
cells in the inner cell mass (Robinson et al., 1994; Walker et al., 1996) which often leads to 
postnatal complications (Kwong et al., 2000; Barker, 2001). Nutritionally challenged women 
(Barker et al., 1993; Godfrey et al., 1996; Ravelli et al., 1988; Godfrey and Barker, 2000) and 
ewes (Whorwood et al., 2001) during the first half of gestation have been found to produce 
longer and thinner babies. Similarly, early nutrient restriction in the bovine has been reported to 
cause a decrease in fetal and placentome weight (Vonnahme et al., 2007) and an increase in the 
cotyledonary arteriolar vascularity (Zhu et al., 2007) at the end of nutrient restriction. These 
studies strongly indicate that alterations in placental function might be a result of maternal under-
nutrition during early gestation.  
Bradykinin (BK) is potent vasodilator associated with enhanced blood flow to the utero-
placenta during gestation (Albertini et al., 1980). The exact mechanisms of BK mediated 
vasodilation in the bovine placental arteries are not known. Further, the impact of   maternal 
nutrient restriction during early gestation on these mechanisms has not been investigated. 
Therefore, we hypothesize that global maternal nutrient restriction during early gestation in 
pregnant beef cows would alter placental arterial vascular function due to changes in placental 
arterial sensitivity to BK. Further, we hypothesize that placental arterial vasodilation is mediated 
at least partly through the BK2R and that global maternal nutrient restriction may impact the 
pathways mediating BK induced vasodilation in the placental arteries. The objective of this study 
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was to examine the effect of maternal nutrient restriction on mechanisms of BK induced 
vasorelaxation in the bovine placental arteries. 
Materials and Methods 
All procedures involving animals were approved by the North Dakota State University 
(NDSU) Animal Care and Use Committee (#A10001).  
Animals, Diets, and Breeding  
A total of 46 non-lactating, multiparous crossbred beef cows of similar genetic background 
were synchronized using a Select Synch plus progesterone insert (CIDR; Pfizer Animal Health, 
New York, NY) and fixed-time AI (TAI) protocol. At the NDSU Beef Research and Teaching 
Unit (Fargo, ND), cows were assigned to 1 of 6 breeding groups with breeding dates ranging 
from July 13th to October 24th 2011. Cows received GnRH (100 µg as 2 mL of Factrel i.m.; Fort 
Dodge Animal Health, Fort Dodge, IA) and a CIDR on d 0. On d 7 CIDR devices were removed, 
and cows were given an injection of PGF2α (25 mg as 5  mL of Lutalyse i.m., Pharmacia & 
Upjohn Co, Kalamazoo, MI). Estrotect Heat Detectors (Rockway Inc., Spring Valley, WI) were 
used to monitor estrous behavior for a minimum of 72 h. Artificial insemination was performed 
utilizing the AM/PM rule 12 h after the first detected estrus. Cows not detected in estrus after 72 
h received a second GnRH injection and TAI was performed. Inseminated cows were transported 
to the Animal Nutrition and Physiology Center (ANPC; Fargo, ND) within 3 d post-
insemination. From arrival at ANPC until confirmed pregnant, cows were grouped in pens (n = 4 
to 5/pen) and trained to use the Calan gate feeding system. At this time, all cows were fed 
chopped grass hay [8.02% crude protein, 69.2% neutral detergent fiber, 41.5% acid detergent 
fiber, and 57.9% total digestible nutrients (dry matter basis)] and a mineral and vitamin 
supplement to meet net energy recommendations for maintenance and fetal growth and to meet 
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or exceed recommendations for metabolizable protein (MP), minerals, and vitamins (NRC, 2000) 
until pregnancy was confirmed. Hay net energy of maintenance concentration was predicted 
using equations described by Weiss (1993) and NRC (2000). 
On d 27 and 28 post-insemination, pregnancy was confirmed via transrectal 
ultrasonography (500-SSV; Aloka, Tokyo, Japan) using a linear transducer probe (5 MHz). Non-
pregnant cows restarted the same breeding protocol; cows were only subjected to AI twice 
during the experiment. On d 30 of pregnancy, cows (initial BW = 620.5 ± 11.3 kg, BCS = 5.1 ± 
0.1) were randomly assigned to either 100% (C; n = 6) or 60% NRC requirements (R; n = 6). On 
d 85 of gestation cows were euthanized and arteries terminating into the maternal (caruncular, 
CAR) and the fetal (cotyledonary, COT) portions of the placentome were dissected to be used 
for in vitro vasoreactivity assays and mRNA expression.   
The control diet consisted of grass hay fed to meet 100% NE recommendations for 
maintenance and fetal growth (NRC, 2000) and to meet or exceed MP, mineral, and vitamin 
recommendations. Nutrient restricted cows received 60% of the same control hay diet. Cows 
were individually fed once daily in a Calan gate system at 1000 and had free access to water. The 
mineral and vitamin supplement (Trouw dairy VTM with optimins; Trouw Nutrition 
International, Highland, IL) was top-dressed 3 times per week at a rate of 0.18% of hay dry 
matter intake to meet or exceed mineral and vitamin requirements relative to dietary net energy 
intake (NRC 2000). Cows were weighed weekly at approximately 0800 throughout the 
experiment and dietary intake was adjusted relative to BW. 
 
 
 
 
 
57 
 
Tissue Collection and Preparation 
Experimental drugs and solutions used in organ chamber studies 
The following drugs were used: Bradykinin (BK; Sigma Chemical Co., St Louis, MO, 
USA), norepinephrine (NE; Sigma); 9, 11-dideoxy-11α,9α-epoxymethano-PGF2α (U46619; 
Cayman Chemical Company, Ann Arbor, MI, USA), icatibant acetate (HOE 140; Sigma), 
iberiotoxin (IbTX; Tocris Biosciences, Minneapolis, MN, USA), N(nitro)-L-arginine (NLA; 
Sigma) and indomethacin (INDO; Sigma). Drug solutions were prepared daily, kept on ice and 
protected from light until use. The BK was initially dissolved in distilled water followed by 
subsequent dilution preparations in distilled water and INDO was dissolved in 100mM Na2CO3 
and the mixture was sonicated for 30 minutes. All the other drugs preparations were dissolved in 
distilled water. Drugs were added to organ chambers in volumes not greater than 0.2 ml/ 25 ml 
or 5 ml of physiological saline solution (PSS). Drug concentrations are reported as final molar 
concentration in the organ chamber. The PSS is a modified Krebs solution with the following 
composition (in mM): NaCl, 118.3; KCl, 4.7; CaCl2, 2.5; MgSO4, 1.2; KH2PO4, 1.2; NaHCO3, 
25.0; and glucose, 11.1 (pH = 7.4). 
Organ chamber studies 
The CAR arterial rings were suspended in water-jacketed organ chambers filled with 25 
ml of PSS. The organ chamber solution was aerated with a mixture of 95% O2/5% CO2 and 
maintained at a temperature of at 37˚C throughout the experiment. Five CAR arterial rings were 
suspended by means of two fine stainless-steel wire clips that passed through the lumen; one clip 
was anchored inside the organ chamber, the other was connected to a force transducer (Model 
FT03, Grass Instrument Company, Quincy, MA, USA). The arterial ring preparations were 
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allowed to equilibrate for 45 min. Isometric tension in the vessels was measured and recorded on 
a Grass polygraph. The rings were stretched progressively at an interval of 10 min each to obtain 
an optimal point of their length–active tension relationship, as determined by the contractile 
response generated in response to KCl (20 mM). Every application was followed by rinsing the 
arterial preparation twice with PSS. After this procedure, the preparations were allowed to 
equilibrate at their optimal length for at least 30 min prior to further exposure to any vasoactive 
substances. The presence of an intact endothelium was confirmed in each preparation by treating 
arterial rings to the endothelium-dependent vasodilator, BK (10
-7 
M). A successful vasodilation 
established the presence of a functional endothelium and the arterial rings which were suspected 
of a damaged endothelium were replaced with a new arterial segment. The preparations were 
then rinsed three times for 45 min with PSS until they relaxed to baseline tension.   
Relaxation of placental arteries was studied in rings contracted with NE (10
-6 
M). After 
the NE induced contraction had reached a stable plateau, relaxation responses to increasing 
concentrations of BK (10
-10 – 10-6 M) were obtained. In addition, BK concentration response 
curves (CRCs) were obtained for rings which were incubated for 30 min with a BK2 receptor 
(BK2R) antagonist, HOE 140 (10
-6 
M); large conductance Ca
2+ 
activated K
+
 channels (BKCa 
channels), IbTX (10
-7 
M); endothelial nitric oxide synthase (eNOS) inhibitor, NLA (10
-5
 M); and 
prostacyclin (PGI2) inhibitor, INDO (10
-5
 M).   
In a separate series of experiments, four COT placental arterial rings were suspended in 
organ chambers of a multi wire myograph system (DMT- 620M, Ann Arbor, MI, USA) filled 
with 5 ml of PSS aerated with mixture of 95% O2/5% CO2. A heat exchanger maintained the 
temperature of the circulating PSS constant at 37˚C. Preparations were threaded onto two wires 
passing through the lumen of the artery. The wires were secured to a tension transducer which 
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measured isometric tension in the vessel and a displacement device which allowed for the control 
of ring circumference.  
The arterial ring preparations were allowed to equilibrate for 30 min. Isometric tension 
was measured and directly recorded on a Power Lab data acquisition system (AD instruments, 
Colorado Springs, CO). The rings were stretched progressively at an interval of 10 min each to 
obtain an optimal point of their length–active tension relationship, as determined by the 
contractile response generated in response to KCl (20 mM). Every application was followed by 
rinsing the arterial preparation twice. The organ chamber solution was drained each time and 
replaced with warm PSS. After this procedure, the preparations were allowed to equilibrate at 
their optimal length for at least 30 min prior to further exposure to any vasoactive substances. 
The presence of an intact endothelium was confirmed in each preparation by treating arterial 
rings to the endothelium-dependent vasodilator, BK (10
-7 
M). Successful vasodilation established 
the presence of a functional endothelium and arterial rings suspected of a damaged endothelium 
were replaced with a new arterial segment. The preparations were then rinsed three times for 40 
min with PSS until they relaxed to baseline tension.   
Relaxation of placental arteries was studied in rings contracted with U46619 (10
-6
 M), a 
thromboxane A2-mimetic. After the U46619 induced contraction reached a stable plateau, 
relaxation responses to increasing concentrations of BK (10
-10 – 10-6 M) were obtained. In 
addition, BK CRCs were obtained for rings which were incubated for 30 min with a BK2R 
antagonist, HOE 140 (10
-6 
M); BKCa channels, IbTX (10
-7 
M); and eNOS inhibitor, NLA (10
-5
 
M). The effects of PGI2 in the COT placental arteries were not examined due to space. 
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Receptor Quantification 
Tissue extraction  
On d 85 of gestation, arteries terminating in the CAR and COT portions of the 
placentome were isolated for BK2R mRNA expression analysis. The placental vessels were 
dissected free from the surrounding placental tissue. The dissected CAR and COT placental 
arteries were frozen in liquid nitrogen and stored at -80˚C for subsequent mRNA analysis. 
Quantification of mRNA 
Frozen arterial tissues (30mg) were suspended in commercially available lysis buffer 
(Qiagen, Valencia, CA, USA) and directly homogenized using a Polytron homogenizer 
(Kinematica Type PT10/35, Brinkman Instrument Inc., Westbury, NY, USA) fitted with a 7mm 
generator. Total mRNA was extracted using a QIAshredder spin column and an RNeasy Mini 
Kit (Qiagen) following manufacturer’s suggested protocol. RNA was quantified by measuring 
absorbance on a Nanodrop 2000c spectrophotometer. 
For each CAR and COT placental arterial tissue, mRNA was reverse transcribed to 
cDNA using QuantiTect Reverse Transcription Kit (Qiagen). Genomic DNA was removed and 
Quantitative RT-PCR on an ABI 7000 sequence detection system (Applied Biosystem, Foster 
City, CA, USA) was performed. The probe and primer sequences for BK2R (ABI, pre-developed 
assay reagent- primers and VIC- TAMRA probe) are as follows: 
Probe: 5’–6FAMCAACAGCTGCCTCAACCCCCTGGTAMRA– 3’ 
(FAM – Reporter, TAMRA – Quencher) 
BK2R– FP: 5’–TCGCGTCCTTTGTGGCTTAC– 3’ 
BK2R– RP: 5’–CGCTTGCCCACGATCAC– 3’ 
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  All reactions were carried out in a 12.5 µL reaction mixture containing, 2µl of cDNA and 
10.5 µL of PCR Master Mix (TaqMan universal PCR master mix (2X), forward primer (1µM), 
reverse primer (1µM), probe (200nM), and ddH20). Dissociation curves confirmed a single 
amplification species for BK2R. The endogenous control, 18s rRNA was used for normalization 
of the raw data. 
Data Analysis 
Vasoreactivity assays and quantification of mRNA 
Data were analyzed within a day. Relaxation responses are expressed as a percentage of 
the initial tension induced by NE in CAR and U46619 in COT placental arteries. For each 
vasoactive agent, both the maximal percent response (Emax) and the concentration necessary to 
produce 50% of its own maximal response (EC50) were determined. The EC50 values were 
converted to the negative logarithms and expressed as -log molar EC50 (pD2). The effects of 
maternal diet on dependent variables were tested using PROC GLM of SAS (SAS software 
version 9.2, SAS Institute, Cary, NC) and means were separated using the LSMEANS statement. 
The class statement included the effects of dietary treatment, dose, and the dietary treatment by 
dose interaction within a tissue (COT or CAR) for responses to BK in the presence and absence 
of the various inhibitors tested. The effect of dietary treatment was also tested on Emax and pD2 
data. Gene expression was quantified as a ratio of BK2R to 18s rRNA. The effects of maternal 
diet on dependent variables were tested using PROC GLM of SAS and means were separated 
using the LSMEANS statement. The model statement included: BK2R to 18s rRNA ratio, delta 
CT, and the percentage change from control. Results are expressed as LSmeans ± SEM and n 
refers to the number of animals from which the placental arteries were derived. Data from some 
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animals were not used in the study if an artery was unresponsive or was found to be an overall 
outlier.  
Results 
Caruncular Arterial Responses 
The treatment by dose interaction on the BK response curve was not significant (P = 
0.95) in the CAR arteries (Figure 2.1A) but, there was an overall effect of maternal nutrition 
during early in gestation. A similar pattern of relaxation was observed in arteries from the C-NI 
and the R-NI cows where R-NI cows were more sensitive (P < 0.0001) to BK (10
-10
 – 10-6 M) 
induced vasodilation than the C-NI cows. While there was a tendency for a lower (P = 0.07) Emax 
value in the arteries from the R-NI cows (18.38 ± 11.97) vs the C-NI cows (52.54 ± 10.75), the 
pD2 values were not influenced (P = 0.74; 7.95 ± 0.41 and 7.74 ± 0.46 for C-NI and R-NI, 
respectively) by the maternal diet for BK CRC.  
There was no treatment by dose interaction when arteries were incubated with HOE 140; 
however, an overall effect of maternal nutrition was observed which blocked BK mediated 
vasodilation in the C-HOE 140 vs C-NI (P < 0.0001) arteries (Figure 2.1B) and R-HOE 140 vs 
R-NI (P < 0.0001) arteries (Figure 2.1F). The Emax values tended to be higher in the presence of 
HOE 140 in the C-HOE 140 (P = 0.06, 84.91 ± 10.39) vs C-NI (52.54 ± 10.39) arteries and R-
HOE 140 (P = 0.08, 65.27 ± 15.89) vs R-NI (18.38 ± 15.89) arteries; while the pD2 values did 
not significantly differ among the C (P = 0.68; 7.95 ± 0.50 vs 7.63 ± 0.56 for C-NI and C-HOE 
140, respectively) and the R (P = 0.73; 7.74 ± 0.69 vs 8.12 ± 0.79 for R-NI and R-HOE 140, 
respectively) treatment groups for HOE 140. 
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In the CAR placental arteries, the BK CRCs had a significant treatment by dose 
interaction in the presence of IbTX. Relaxation was abolished in the C-IbTX vs C-NI (P = 0.001) 
(Figure 2.1C) and R-IbTX vs R-NI (P = 0.04) arteries (Figure 2.1G). Incubation with IbTX led to 
an increase in the Emax values in the C-IbTX (P = 0.004; 93.91 ± 7.4) vs C-NI (52.54 ± 8.11) 
arteries and the R-IbTX (P = 0.006; 104.92 ± 14.84) vs R-NI (18.38 ± 14.84) arteries; while the 
pD2 values did not differ among the C (P = 0.36; 7.95 ± 0.37 vs 7.41 ± 0.42 for C-NI vs C-IbTX, 
respectively) and R (P = 0.68; 7.74 ± 0.53 vs 8.07 ± 0.53 for R-NI vs R-IbTX, respectively) 
treatment groups for IbTX.  
When incubated with NLA, a treatment by dose interaction was observed and C-NLA (P 
= 0.02) and R-NLA (P = 0.04) arteries did not relax when compared with C-NI (Figure 2.1D) 
and R-NI (Figure 2.1H) arteries. Moreover, the maternal diet had a significant impact on the Emax 
values in the presence of NLA resulting in higher Emax values in the C-NLA (P = 0.024; 85.56 ± 
8.2) vs C-NI (52.54 ± 8.98) and R-NLA (P = 0.005; 76.86 ± 9.53) vs R-NI (18.38 ± 9.53) 
arteries. The BK CRCs pD2 values for C (P = 0.37; 7.95 ± 0.27 vs 8.32 ± 0.27 for C-NI vs C-
NLA, respectively) and R (P = 0.37; 7.74 ± 0.50 vs 8.43 ± 0.50 for R-NI vs R-NLA, 
respectively) arteries did not differ for NLA.  
For CAR placental arteries incubated with INDO, the treatment by dose interaction was 
not significant (P ≥ 0.23); however, an effect of maternal diet was observed in the presence of 
INDO which inhibited relaxation in the C (P < 0.0001) (Figure 2.1E) and R (P < 0.0001) cows 
(Figure 2.1I). Maternal diet also had an impact on the Emax values which were higher in C-INDO 
(P = 0.05; 83.25 ± 9.0) and R-INDO (P = 0.01; 67.13 ± 9.75) arteries vs C-NI (52.54 ± 9.87) and 
R-NI (18.38 ± 10.89) arteries. The BK CRCs pD2 values did not significantly differ among the C 
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(P = 0.37; 7.95 ± 0.34 vs 8.41 ± 0.34 for C-NI and C-INDO, respectively) and R (P = 0.93; 7.74 
± 0.56 vs 7.82 ± 0.56 for R-NI and R-INDO, respectively) treatment groups for INDO. 
Cotyledonary Arterial Responses  
In the COT placental arteries, there was a treatment by dose interaction and an effect of 
treatment was observed when arteries were treated with BK (Figure 2.2A). The C-NI and R-NI 
arteries responded similarly until the 3 × 10
-7
 M dose of BK after which the R-NI arterial rings 
showed higher sensitivity (P = 0.04) to BK (10
-10
 – 10-6 M) induced vasodilation compared with 
the C-NI arterial rings. While the dietary treatment led to a lower (P < 0.01) Emax value in the 
arteries from the R-NI (42.77 ± 9.04) vs the C-NI (83.08 ± 7.38) cows the pD2 values did not 
differ (P = 0.07; 8.13 ± 0.69 vs 5.90 ± 0.69 for C-NI and R-NI, respectively) for BK CRC.  
The COT arterial rings incubated with HOE 140 had a significant treatment by dose 
interaction; however, this effect was only observed in C (P < 0.0001) cows. The C-NI and C-
HOE 140 arteries responded similarly to BK until the 3 × 10
-8
 M dose of BK (Figure 2.2B). 
Beginning at the 10
-7
 M dose of BK, vasodilation continued to be completely abolished (i.e. 
100%) in the C-HOE arteries whereas, the C-NI arteries relaxed. Furthermore, the maternal diet 
led to a higher Emax value in the presence of HOE 140 (P < 0.0001; 83.08 ± 7.35 vs 148.92 ± 7.35 
for C-NI and C-HOE 140, respectively) in the C arteries, while the pD2 values (8.13 ± 0.71 vs 
8.18 ± 0.64 for C-NI and C-HOE 140, respectively) were similar.  
In the R arteries, there was a tendency for a treatment by dose interaction (P = 0.07) and 
an effect of the dietary treatment (P = 0.004) was observed upon incubation with HOE 140 
(Figure 1.2E). The R-NI and R-HOE 140 arteries responded similarly to BK until the 3 × 10
-7
 M 
dose of BK (Figure 2.2E). Beginning at the 10
-6 
M dose of BK, relaxation was inhibited in the C-
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HOE 140 arteries whereas, the C-NI arteries showed higher sensitivity to BK induced 
relaxations. The BK dose response Emax values tended to be higher in the presence of HOE 140 
(P = 0.07; 42.77 ± 16.75 and 94.25 ± 16.75 for R-NI and R-HOE 140, respectively) in the R 
placental arteries while, the pD2 values (P = 0.17; 5.90 ± 0.62 vs 7.27 ± 0.62 for R-NI and R-
HOE 140, respectively) were not influenced by the maternal diet for HOE 140.   
The C arterial rings, had a significant treatment by dose interaction (P = 0.003) in the 
presence of IbTX (Figure 2.2C). Similar patterns of relaxations were observed until the 10
-8 
M 
dose of BK, after which the BK induced relaxation, was enhanced in the C-IbTX arteries vs the 
C-NI arteries. The C-NI arteries (83.08 ± 9.55) had a greater (P = 0.03) Emax value than the C-
IbTX (47.69 ± 9.55) arteries while the pD2 values did not differ (P = 0.11; 8.13 ± 0.61 vs 6.73 ± 
0.49 for C-NI and C-IbTX, respectively). In the R arterial rings, there was no treatment by dose 
interaction (P = 0.98) but, a tendency for a treatment effect (P = 0.09) and an effect of dose was 
significant (P < 0.0001) where the R-NI and R-IbTX arteries responded similarly to BK induced 
vasodilation (Figure 2.2F). Dietary treatment had no impact on the Emax values (P = 0.94; 42.77 ± 
7.92 vs 43.62 ± 7.92 for R-NI and R-IbTX, respectively) and pD2 values (P = 0.34; 5.90 ± 0.32 
vs 6.37 ± 0.32 for R-NI and R-IbTX, respectively) in the R arteries in the presence of IbTX.  
In the COT placental artery, a significant treatment by dose interaction was observed 
when arterial rings were incubated with NLA. Regardless of maternal nutrition, relaxation was 
completely abolished (i.e. 100%) in the C (P < 0.0001) (Figure 2.2D) and R (P < 0.0001) (Figure 
2.2G) arteries. Moreover, the Emax values were significantly higher (P < 0.0001; 83.08 ± 9.22 vs 
164.33 ± 9.22 for C-NI and C-NLA, respectively; P < 0.0001; 42.77 ± 8.00 vs 148.69 ± 8.00 for 
R-NI and R-NLA, respectively) in COT arteries treated with NLA for both the C and the R 
treatment groups. Additionaly, dietary treatment had an effect on the pD2 values in the R cows 
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where a leftward shift (P = 0.0004; 5.90 ± 0.23 vs 8.26 ± 0.23 for R-NI and R-NLA, 
respectively) was observed in BK CRC in the presence of NLA while, the pD2 values in the C 
cows (P = 0.95; 8.13 ± 0.64 vs 8.19 ± 0.52 for C-NI and C-NLA, respectively) were similar.  
Caruncular and Cotyledonary Arterial Responses to Bradykinin 
The CRCs comparing the effects of BK on the C-CAR vs C-COT and R-CAR vs R-COT 
are depicted in figures 2.3A and 2.3B. A treatment by dose interaction was observed and the 
sensitivity to BK induced relaxation in the CAR placental arteries was enhanced in C-CAR (P = 
0.02) and R-CAR (P = 0.007) vs C-COT and R-COT arteries. There was an effect of dietary 
treatment on the Emax values (P < 0.05) in the C-CAR (52.54 ± 9.94) vs C-COT (83.08 ± 9.07) 
arteries while the pD2 values (P = 0.85; 7.95 ± 0.61 vs 8.13 ± 0.69 for C-CAR and C-COT, 
respectively) did not differ. Maternal nutrition also had a significant effect on the pD2 values (P = 
0.02) in the R-CAR (7.74 ± 0.43) vs R-COT (5.90 ± 0.43) arteries while the Emax values were 
similar (P = 0.12; 18.38 ± 9.54 vs 42.77 ± 9.54 for R-CAR and R-COT, respectively). 
BK2R mRNA Expression 
Maternal dietary treatment did not influence the mRNA expression of BK2R in the CAR 
(P = 0.51; 1.18, 1.29 ± 0.11 arbitrary units for C and R, respectively) and the COT (P = 0.97; 
1.25, 1.26 ± 0.14 arbitrary units for C and R, respectively) placental arteries.  
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Figure 2.1. The impacts of maternal nutrition and bradykinin (BK) dose on the BK 
concentration response curve in carnuncular (CAR) arteries (A) in the absence of an inhibitor 
(no inhibitor, NI), (B, F) after incubation with icatibant acetate (HOE 140), (C, G) after 
incubation with iberiotoxin (IbTX), (D, H) after incubation with N(nitro)-L-arginine (NLA), and 
(E, I) after incubation with indomethacin (INDO). Animals received either 100% (C) or 60% 
(R) of NRC requirements. Diets were fed from d 30 to d 85 of gestation. 
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Figure 2.2. The impacts of maternal nutrition and bradykinin (BK) dose on the BK 
concentration response curve in cotyledonary (COT) arteries (A) in the absence of an inhibitor 
(no inhibitor, NI), (B, E) after incubation with icatibant acetate (HOE 140), (C, F) after 
incubation with iberiotoxin (IbTX), and (D, G) after incubation with N(nitro)-L-arginine (NLA). 
Animals received either 100% (C) or 60% (R) of NRC requirements. Diets were fed from d 30 to 
d 85 of gestation. 
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Figure 2.3. The impacts of maternal nutrition and bradykinin (BK) dose on the BK 
concentration response curve in the caruncular (CAR) and cotyledonary (COT) arteries in cows 
receiving (A) 100% (C) of NRC requirements and (B) 60% (R) of NRC requirements. Diets 
were fed from d 30 to d 85 of gestation. 
Discussion 
Bradykinin, a nonapeptide kinin, is a stimulator of vascular permeability (Bhoola et al., 
1992) and a potent vasodilator which enhances blood flow to the uterus during estrous cycle 
(Resnick et al., 1976) and the utero-placenta during gestation (Albertini et al., 1980). In addition, 
BK promotes angiogenesis, vascular permeability (Valdéz and Corthorn, 2011) and exerts its 
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physiological effects on the cardiovascular system by acting on the vascular endothelium (Hong, 
1980; Cocks et al., 1985; Palmer et al., 1987; Gryglewski et al., 1986; Mombouli et al., 1996; 
Bas et al., 2007) via the the BK1 receptor and the BK2 receptor (BK2R) (Bhoola et al., 1992; 
Leeb-Lundberg et al., 2005), the latter being the predominant receptor type (Bas et al., 2007). 
The endothelial BK2R (Bhoola et al., 1992; Marceau et al., 1998; Christiansen et al., 2002; 
Marceau and Regoli, 2004; Souza et al., 2004; Moreau et al., 2005) promotes the release of 
endothelium derived vasodilatory mediators: nitric oxide (NO) (Furchgott and Zawadzki, 1980; 
Ignarro et al., 1981,1989; Bian and Murad, 2003; Furchgott, 1995; Moncada et al., 1991; Tanaka 
et al., 2004), prostacyclin (PGI2) (Moncada et al., 1976; Coleman et al., 1994; Narumiya et al., 
1999; Wise and Jones, 1996; Tanaka et al., 2004), and endothelium derived hyperpolarizing 
factors (EDHF(s)) (Nagao and Vanhoutte, 1993; McGuire et al., 2001; Busse et al., 2002; 
Suzuki, 2003; Triggle et al., 2003) for mediating vasorelaxation (Magness et al., 1993; Gainer et 
al., 1998).  
The findings of this study reveal that global maternal nutrient restriction during early 
gestation (d 30 to d 85) increases the sensitivity of the CAR and the COT placental arteries in the 
R-NI cows to vasorelaxation compared with the C-NI cows in response to BK. These findings 
represent an important underlying mechanism by which dietary treatment alters placental 
vasoactivity which may impact uterine-umbilical blood flows and nutrient availability to the 
developing fetus. These conclusions are supported by the fact that the increase in sensitivity of 
the R-NI cows to BK induced relaxation allowed for compensatory placental growth resulting in 
enlarged placentas in cattle, as reported by our laboratory (Camacho et al., 2012). This increase 
in placental mass may have allowed for the tendency for increased fetal weight by increasing 
nutrient availability to the nutrient restricted cows (Camacho et al., 2012). These data are similar 
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to those of Lao and Wong (1996) who observed placental enlargement as an adaptive response 
induced as a result of lack of oxygen or nutrients and Lumey (1998), who also reported the 
delivery of heavier and enlarged placentas at term by nutritionally challenged human mothers 
during the first trimester of pregnancy. Similar to humans, compensatory placental growth was 
also observed in various models of undernourished ewes from early to mid-gestation (Owens et 
al., 1986; McCrabb et al., 1986, 1991; Faichney and White, 1987). 
A successful pregnancy in all mammals is energetically costly and marks a 20-50% 
increase in the maternal metabolic rate (Brody, 1938; Ferrell et al., 1976; Ferrell and Jenkins, 
1985; Robson et al., 1989; Stock and Metcalfe, 1994) primarily supporting the dramatic 
alterations in the maternal cardiovascular system and the utero-placental vascular bed (Rosenfeld 
and Fixler, 1977; Reynolds and Redmer, 1995; Magness, 1998) ensuring optimum fetal growth 
and development (Reynolds and Redmer, 1995; Reynolds et al., 2010). The placenta undergoes a 
variety of physiological changes to adapt to the various environmental stressors to drive fetal 
programming. Intrauterine growth restriction which is often caused by maternal under-nutrition 
during gestation can lead to stunted placental and fetal growth and development (Barker, 1997). 
Therefore, the development of potential therapeutics aimed at enhancing placental efficiency to 
promote nutrient delivery to the fetus would potentially be beneficial in overcoming 
compromised pregnancies (Reynolds et al., 2006, 2010).    
In order to investigate the pathway responsible for BK induced relaxation, the CAR and 
the COT placental arteries were incubated in the presence of various inhibitors. The results of the 
present study show that the dietary treatment during early gestation influences vasorelaxation 
produced in response to BK which exerts its effects via the BK2R in the C and R cows in both 
CAR and COT placental arteries. Furthermore, BKCa channels are involved in mediating 
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relaxation in the CAR arteries; whereas, in the COT arteries, relaxation was enhanced upon 
incubation with IbTX in the C cows while no effect was observed in the R cows. In the current 
study, the C-IbTX and R-IbTX COT placental arteries relaxed despite blocking the BKCa 
channels. Since, the EDHF(s) are representative of a diverse group of chemical compounds 
comprising of L-citrulline, K
+
 ion, H2O2, anandamide, and epoxyeicosatrienoic acids (Tanaka et 
al., 2004), it is quite possible that the observed relaxation in the COT placental arteries is likely 
due to an EDHF that is not inhibited by IbTX. This could possibly be a compensatory 
mechanism employed by the R COT placental arteries to ensure optimum nutrient delivery to the 
fetus. Therefore, further investigation of EDHF(s) is required which might provide a potential 
mechanism by which dietary treatment could potentiate BK induced relaxation in the COT 
placental arteries. In the presence of NLA, relaxation was inhibited in both, the CAR and the 
COT arteries pointing out the pivotal role of NO in mediating vasodilation in the placental 
arteries. Moreover, the Emax values of C-NLA and R-NLA arteries were significantly greater in 
the CAR and the COT arteries suggesting that the primary vasodilator is likely NO released from 
the endothelial cells in response to BK. Incubation with INDO inhibited vasorelaxation in the 
CAR placental arteries indicating the involvement of the PGI2 pathway in mediating BK induced 
vasorelaxation.  
 The mRNA expression of the BK2R analyzed in the present study did not differ among 
the two treatment groups in both the CAR and the COT placental arteries, implying that while 
the receptor gene expression is not altered by nutritional status, enhanced BK activity must be 
augmented downstream from the predominant receptor type. These findings further emphasize 
the importance of vasoreactivity assays rather than relying on mRNA expression data as the sole 
determinant.  
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Lastly, it is of interest to note that maternal nutrient restriction during early gestation 
significantly enhances BK induced relaxation in the CAR arteries compared with the COT 
arteries from the C and the R cows. These results are important as they suggest that CAR 
vascular bed is more sensitive to BK induced vasodilation than the COT vascular bed during 
early gestation (d85) which is critical time for placental growth and development. This increased 
sensitivity could allow for an efficient nutrient delivery system to the fetus and may lay a 
foundation for the production of a healthy and viable offspring. 
Taken together, the results of the present study support our hypothesis that global 
maternal nutrient restriction during early gestation in pregnant beef cows alters sensitivity of the 
CAR and the COT arteries to BK induced relaxation which is mediated by the BK2R and at least 
partly by the pathways mediating BK induced vasodilation in the placental arteries. Further 
investigations are required in the area of bovine maternal and fetal placental development during 
mid and late gestation and how potential therapeutics may impact compromised pregnancies in a 
cow. 
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CHAPTER 3. INFLUENCE OF MATERNAL NUTRIENT RESTRICTION AND EARLY 
RESTRICTION FOLLOWED BY REALIMENTATION DURING MID-GESTATION 
ON PLACENTAL VASCULAR FUNCTION IN PREGNANT BEEF COWS 
Abstract 
We hypothesize that maternal nutrient restriction during early and mid-gestation and 
early restriction followed by realimentation would alter the caruncular (CAR) and cotyledonary 
(COT) placental artery sensitivity to bradykinin (BK) induced relaxation. Further, we 
hypothesized the placental arterial vasodilation is mediated at least partly through the bradykinin 
2 receptor (BK2R) and its pathways which may be impacted by the maternal diet. To examine 
the effects of maternal nutrient restriction and realimentation on CAR and COT artery 
vasoactivity during mid-gestation, multiparous beef cows on d 30 of gestation were randomly 
assigned to receive 100% (d 30 to d 140) NRC requirements (CC; n = 6), 60% (d 30 to d 85) 
followed by 100% (d 85 to d 140) NRC requirements (RC; n = 5), and 60% NRC (d 85 to d 140) 
requirements (RR; n = 6). At d 140 of gestation cows were euthanized and arteries that 
terminated into the maternal (CAR artery) and fetal portions (COT artery) of the placentome 
were dissected to be used for in vitro vasoreactivity assays and mRNA expression. The 
endothelium-intact CAR arterial rings were loaded in an organ bath chamber and contracted with 
NE (10
-6
 M) and the concentration response curve (CRC) to BK was obtained. In addition, a BK 
CRC was obtained for rings which were incubated for 30 min with inhibitors to: 1) BK2R, 
icatibant acetate (HOE 140; 10
-6 
M); 2) large conductance Ca
2+ 
activated K
+
 channels, 
iberiotoxin (IbTX; 10
-7 
M); 3) endogenous nitric oxide synthase, N(nitro)-L-arginine, (NLA; 10
-5
 
M); and 4) prostacyclins (PGI2), indomethacin (INDO; 10
-5
 M). Additionally, endothelium-intact 
COT arterial rings were contracted with U46619 (10
-6
 M) and the effect of BK and the above 
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mentioned inhibitors were studied with the exception of PGI2. The CAR arterial rings with no 
inhibitor (NI) were influenced by the maternal diet and arteries from the RR cows were more 
sensitive (P = 0.004) to BK induced relaxation than the CC cows while they tended to relax more 
than the RC cows. Incubation with HOE 140 delayed relaxation (P < 0.03); however, the CAR 
arteries responded similarly at higher doses indicating the presence of an alternate mechanism or 
regulation of vasodilation partly via the BK1R in conjunction with the BK2R type. An effect of 
dietary treatment was observed in the presence of IbTX and NLA which inhibited relaxation (P < 
0.0001) suggesting that BKCa channels and NO are involved in mediating relaxation in the CAR 
placental arteries. The CAR arteries from the RR cows had an effect of maternal diet upon 
incubation with INDO which inhibited relaxation (P < 0.0001) while no effect was observed in 
the CC (P = 0.59) and the RC (P = 0.57) arteries indicative of a compensatory mechanism 
employed by the CAR restricted arteries to overcome a longer period of nutrient restriction. In 
the COT placental arteries, the CC and the RR cows responded similarly and showed increased 
sensitivity (P = 0.01) to BK compared with the RC cows where relaxation was delayed. Arteries 
incubated with HOE 140 had a significant treatment by dose interaction which abolished (P < 
0.0001) BK mediated relaxation. However, inhibition of BKCa channels failed to attenuate (P > 
0.06) the BK response, indicating that BKCa channels may not be involved in BK responses in 
COT arteries. There was a treatment by dose interaction and NLA blocked (P < 0.0001) BK 
induced relaxation of COT arteries in all treatments. The mRNA expression of BK2R in 
placental arteries was not altered (P ≥ 0.50) by the maternal diet during mid-gestation. Our 
findings reveal that the CAR and the COT placental arteries respond to BK through different 
mechanisms.  
Key words: bradykinin, cow, placenta, vascular function 
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Introduction 
Mid-gestation in the bovine is marked by maximal placental growth and differentiation 
(Barcroft and Barron, 1946; Metcalfe et al., 1988; Ferrell, 1989; Reynolds and Redmer, 1995; 
Bell et al., 1999) which continues to keep pace with the ever increasing fetal demands 
throughout gestation. Maternal nutrition during this crucial period of placental establishment has 
a significant impact on the fetal growth (Wallace, 1948; Wallace et al., 1999a; Godfrey and 
Barker, 2000). Numerous animal models investigating the effects of maternal diet in the ewes 
and cows have obtained variable results on the placental and fetal growth during mid-gestation in 
both species. Specific studies investigating the effects of realimentation in the bovine have 
produced contrasting results in the caruncular (CAR) and cotyledonary (COT) placental tissues 
(Vonnahme et al., 2007; Zhu et al., 2007). 
As previously described (Reyaz, Chapter 2), our laboratory found that maternal nutrient 
restriction during early gestation resulted in increased sensitivity to bradykinin (BK) in the CAR 
and the COT placental arteries in the bovine. This increased sensitivity of placental arteries to 
BK may be a compensatory mechanism in the cow to overcome maternal nutrient restriction 
during early gestation. In order to further investigate the effect of dietary treatment during mid-
gestation, vasoactivity assays were performed. We hypothesized that global maternal nutrient 
restriction during early and mid-gestation and early restriction followed by realimentation would 
alter placental arterial vascular function due to changes in placental arterial sensitivity to BK. 
Further, we also hypothesized that placental arterial vasodilation is mediated at least partly 
through the BK2R and that global maternal nutrient restriction may impact the pathways 
mediating BK induced vasodilation in the placental arteries. Thus, the objective of this study was 
to examine the effects of global maternal nutrient restriction and early restriction followed by 
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realimentation during mid-gestation on the mechanisms of BK induced vasorelaxation in the 
placental arteries of cow. 
Materials and Methods 
 All procedures involving animals were approved by the North Dakota State University 
(NDSU) Animal Care and Use Committee (#A10001).  
Animals, Diets, and Breeding  
Animal breeding was similar as described in chapter 2; however, the durations of the 
applied dietary treatments were different. On d 30 of gestation multiparous beef cows were 
randomly assigned to receive 100% (d 30 to d 140) NRC requirements (CC; n = 6), 60% (d 30 to 
d 85) followed by 100% (d 85 to d 140) NRC requirements (RC; n = 5), and 60% NRC (d 85 to 
d 140) requirements (RR; n = 6). At d 140 of gestation cows were euthanized and arteries 
terminating into the maternal (caruncular, CAR) and the fetal (cotyledonary, COT) portions the 
placentome were dissected to be used for in vitro vasoreactivity assays and mRNA expression. 
Tissue collection, experimental drug preparations, organ chamber studies, receptor 
quantification and data analysis methods are same as described in chapter 2.   
Results 
Caruncular Arterial Responses 
In the CAR arteries, the treatment by dose interaction on the BK CRCs was not 
significant (P = 0.99) however, an effect of dietary treatment (P = 0.004) was observed (Figure 
2.1A). The arteries from the RR-NI cows were more sensitive (P < 0.001) to BK (10
-10
 – 10-6 M) 
induced vasodilation than arteries from the CC-NI cows. Moreover, there was a tendency for 
increased (P = 0.088) vasorelaxation to BK in the RR-NI arteries compared with the RC-NI 
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arteries while the RC-NI arteries did not differ (P = 0.11) from the CC-NI arteries. Maternal diet 
neither had an impact on the pD2 values (P = 0.63; 8.67 ± 0.37 vs 8.62 ± 0.29 vs 8.98 ± 0.23 for 
CC-NI, RC-NI and RR-NI respectively) nor the Emax values (P = 0.35; 51.59 ± 11.94 vs 33.22 ± 
11.94 vs 27.78 ± 10.89 for CC-NI, RC-NI and RR-NI respectively) for BK CRCs in CAR 
arteries with no inhibitor (NI).  
The BK dose response curves in the presence of HOE 140 had a significant (P = 0.0003) 
treatment by dose interaction in CC-NI vs CC-HOE 140 arteries (Figure 2.2A). Arterial rings 
responded similarly until the 3 × 10
-9
 M dose of BK. Beginning at 10
-8
 M dose, CC-NI arterial 
rings were more sensitive until 3 × 10
-7
 M dose of BK while relaxation was delayed in CC-HOE 
140 rings. However, at the highest doses of BK (10
-6
 M and 3 × 10
-6
 M), CC-HOE 140 rings 
showed higher sensitivity to BK induced relaxations compared with CC-NI rings. In the RC and 
RR aretries there was no treatment by dose interaction (P ≥ 0.21) upon incubation with HOE 
140. An overall effect of maternal nutrition was observed which delayed BK mediated 
vasodilation in the RC-HOE 140 vs RC-NI (P < 0.0001) arteries (Figure 3.3A) and RR-HOE 140 
vs RR-NI (P < 0.0001) arteries (Figure 3.4A); however, at the highest dose (3 × 10
-6
 M) of BK, 
RC-HOE 140 and RR-HOE140 arteries responded to BK similarly to RC-NI and RR-NI arteries.     
In the CAR placental arteries incubated with HOE 140, the pD2 values were higher in the 
CC-HOE 140 (P = 0.03; 6.58 ± 0.45), RC-HOE-140 (P = 0.03; 6.82 ± 0.49), and RR-HOE 140 
(P < 0.01; 7.02 ± 0.44) arteries compared with CC-NI (8.67 ± 0.52), RC-NI (8.61 ± 0.49), and 
RR-NI (8.97 ± 0.40) arteries. Further, The Emax value of the BK CRCs with HOE 140 was lower 
(P = 0.03) in the CC-HOE140 (22.48 ± 7.99) arteries vs CC-NI (51.59 ± 7.15) arteries while the 
Emax values in the RC (P = 0.65; 33.22 ± 16.96 vs 44.67 ± 16.96 for RC-NI and RC-HOE 140, 
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respectively) and RR (P = 0.77; 27.78 ± 9.99 vs 31.99 ± 9.99 for RR-NI and RR-HOE 140, 
respectively) cows were not influenced by the maternal diet. 
For CAR placental arteries incubated with IbTX, the treatment by dose interaction was 
not significant in CC (P = 0.63), RC (P = 0.23), and RR (P = 0.85) arteries; however, an effect of 
maternal diet was observed which delayed relaxation in the CC-IbTX (P < 0.0001), RC-IbTX (P 
< 0.0001), and RR-IbTX (P < 0.0001) arteries compared with CC-NI (Figure 3.2B), RC-NI 
(Figure 3.3B), and RR-NI (Figure 3.4B) arteries.  
The BK CRCs pD2 values for CAR arteries with NI and CAR arteries incubated with 
IbTX were similar (P = 0.99; 8.67 ± 0.36 vs 8.67 ± 0.28 for CC-NI and CC-IbTX, respectively; 
P = 0.74; 8.62 ± 0.34 vs 8.45 ± 0.37 for RC-NI and RC-IbTX, respectively; P = 0.59; 8.98 ± 0.29 
vs 8.73 ± 0.32 for RR-NI and RR-IbTX, respectively). In the CAR arteries incubated with IbTX, 
maternal diet led to a higher (P = 0.03) Emax value in the RC-IbTX (82.04 ± 13.39) vs the RC-NI 
(33.22 ± 13.39) arteries while the CC-IbTX (P = 0.06; 76.05 ± 7.87) and RR-IbTX (P = 0.07; 
62.17 ± 11.97) had a tendency for a higher Emax than the CC-NI (51.59 ± 7.87) and RR-NI (27.17 
± 11.97) arteries.  
The CAR placental arteries treated with NLA had a tendency for a treatment by dose 
interaction and a significant treatment effect (P < 0.0001) which inhibited relaxation but, this 
effect was only observed in the RC-NLA (P = 0.06) and RR-NLA (P = 0.09) arteries vs RC-NI 
(Figure 3.3C) and RR-NLA (Figure 3.4C) arteries. In the CC-NLA vs CC-NI arteries, the 
treatment by dose interaction was not significant (P = 0.32) but, an effect of dietary treatment (P 
< 0.0001) was observed (Figure 3.2C). The BK response curves for CC-NI and CC-NLA 
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followed a similar relaxation pattern until 3 × 10
-9
 M dose of BK, but after this dose, CC-NI 
arteries were more sensitive to BK mediated vasodilation.  
The pD2 values in CAR arteries incubated with NLA were not influenced (P = 0.65; 8.67 
± 0.17 vs 8.77 ± 0.13 for RR-NI and RR-NLA, respectively; P = 0.22; 8.62 ± 0.23 vs 8.15 ± 0.26 
for RC-NI and RC-NLA, respectively; P = 0.41; 8.97 ± 0.34 vs 8.54 ± 0.38 for CC-NI and CC-
NLA, respectively) by the maternal dietary treatment. Maternal diet did not impact the Emax of 
the BK CRCs incubated with NLA in CC arteries (P = 0.12; 51.59 ± 8.44 vs 71.30 ± 7.70 for 
CC-NI and CC-NLA, respectively); however, RC-NLA (P = 0.04; 78.83 ± 12.90) and RR-NLA 
(P = 0.0002; 80.44 ± 6.37) had greater Emax values compared with RC-NI (33.22 ± 12.90) and 
RR-NI (27.78 ± 6.37) arteries. 
For CAR placental arteries incubated with INDO, neither the treatment by dose 
interaction (P ≥ 0.57) nor an effect of dietary treatment (P = 0.99) was significant in CC-INDO 
vs CC-NI (Figure 3.2D) and RC-INDO vs RC-NI (Figure 3.3D) arteries. However, an effect of 
dose (P < 0.0001) was observed, where the CC and RC placental arteries responded similarly to 
BK in the presence and absence of INDO. However, in the RR arteries, an effect of maternal diet 
was observed in the presence of INDO which delayed relaxation (P < 0.0001) in the RR-INDO 
arteries compared with RR-NI (Figure 3.4D) arteries. 
In the CAR arteries incubated with INDO, the pD2 values were similar (P = 0.88; 8.67 ± 
0.32 vs 8.60 ± 0.27 for CC-NI and CC-INDO, respectively; P = 0.83; 8.62 ± 0.28 vs 8.52 ± 0.31 
for RC-NI and RR-INDO, respectively; P = 0.47; 8.98 ± 0.38 vs 8.47 ± 0.54 for RR-NI and RR-
INDO, respectively). The BK dose response Emax value for CAR arteries in the presence of 
INDO was greater (P < 0.01) in RR-INDO (72.93 ± 10.37) vs RR-NI (27.78 ± 8.47) arteries 
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while no differences were observed on the Emax values in the CC (P = 0.93; 51.59 ± 8.27 vs 
50.56 ± 8.27 for CC-NI and CC-INDO, respectively) and RC (P = 0.81; 33.22 ± 13.20 vs 28.28 
± 14.76 for RC-NI and RC-INDO, respectively) arteries.  
Cotyledonary Arterial Responses  
 In the COT placental arteries, there was a tendency for a treatment by dose interaction (P 
= 0.06) and an overall effect (P = 0.01) of dietary treatment was observed when arteries were 
treated with BK (Figure 3.1B). There was a slight rightward shift in the RC-NI cows compared 
with the CC-NI (P = 0.008) and RR-NI (P < 0.02) cows, while the RR-NI did not differ from 
CC-NI arteries (P = 0.62).  
Moreover, in the COT placental arteries with no inhibitor there was an overall effect (P < 
0.03) of maternal nutrition on the pD2 values. The RC-NI (6.60 ± 0.22) cows had a significantly 
higher (P < 0.01) pD2 value compared with the RR-NI (7.53 ± 0.20) cows. In the RC arteries, the 
pD2 value tended (P = 0.06) to be higher than the CC-NI (7.29 ± 0.25) cows while CC-NI cows 
did not significantly differ (P = 0.48) from the RR-NI cows. Maternal diet had no impact on the 
Emax values (P > 0.49; 21.09 ± 9.22 vs 23.77 ± 8.25 vs 29.63 ± 7.53 for CC-NI, RC-NI, and RR-
NI, respectively) for the BK CRCs in COT placental arteries with NI.   
The COT placental artery rings incubated with HOE 140 had a significant treatment by 
dose interaction and relaxation was completely blocked (i.e. 100%) in the CC-HOE 140 (P < 
0.0001), RC-HOE 140 (P < 0.0001), and RR-HOE 140 (P < 0.0001) cows compared with CC-NI 
(Figure 3.5A), RC-NI (Figure 3.6A) and RR-NI (Figure 3.7A) arteries. The CC-HOE 140, RC-
HOE 140, and RR-HOE 140 arteries responded similarly to BK until the 3 × 10
-9
 M, 3 × 10
-8
 M, 
10
-8
 M doses of BK. After these doses, the arteries without an inhibitor were more sensitive to 
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BK induced vasodilation compared with the COT arteries incubated with HOE 140 for the 
remaining doses of BK.  
In COT placental arteries incubated with HOE 140, the pD2 values tended to be higher in 
the RC-NI (P = 0.06; 6.60 ± 0.27) vs RC-HOE 140 (7.41 ± 0.27) arteries while the BK response 
curve pD2 values in the CC (P = 0.37; 7.29 ± 0.52 vs 7.96 ± 0.46 for CC-NI and CC-HOE 140, 
respectively) and RR (P = 0.41; 7.53 ± 0.42 vs 6.98 ± 0.42 for RR-NI and RR-HOE 140, 
respectively) aretries were not affected by the maternal diet. Additionally an effect of dietary 
treatment was observed on the Emax values in the presence of HOE 140. The CC-HOE 140 (P = 
0.0004; 108.54 ± 9.15), RC-HOE 140 (P < 0.0001; 112.82 ± 6.15), and RR-HOE 140 (P = 
0.0002; 103.00 ± 9.36) arteries had a significantly greater Emax values compared with CC-NI 
(21.09 ± 10.23), RC-NI (23.77 ± 6.15), and RR-NI (29.63 ± 9.36) arteries.  
The BK CRCs did not have a significant (P ≥ 0.79) treatment by dose interaction in the 
COT placental arteries treated with IbTX. The CC (P = 0.06) and RC (P = 0.09) cows had a 
tendency for an effect of dietary treatment while the RR cows were not influenced (P = 0.98) by 
the maternal diet. An effect of dose was observed in CC-IbTX, RC-IbTX, and RR-IbTX arteries 
which responded similarly (P < 0.0001) to BK compared with the CC-NI (Figure 3.5B), RC-NI 
(Figure 3.6B), and RR-NI (Figure 3.7B) arteries.   
The BK dose response pD2 values for COT arteries with no inhibitor and CAR arteries 
incubated with IbTX were similar (P = 0.73; 7.29 ± 0.31 vs 7.45 ± 0.31 for CC-NI and CC-IbTX, 
respectively; P = 0.83; 6.60 ± 0.18 vs 6.54 ± 0.18 for RC-NI and RC-IbTX, respectively; P = 
0.35; 7.53 ± 0.19 vs 7.25 ± 0.20 for RR-NI and RR-IbTX, respectively). The COT artery rings 
Emax values in the presence of IbTX were not influenced by the maternal diet in CC (P = 0.79; 
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21.09 ± 9.84 vs 17.12 ± 9.84 for CC-NI and CC-IbTX, respectively), RC (P = 0.55; 23.77 ± 7.52 
vs 17.12 ± 7.52 for RC-NI and RC-IbTX, respectively), and RR (P = 0.21; 29.63 ± 6.42 vs 16.66 
± 7.04 for RR-NI and RR-IbTX, respectively) cows.  
In the COT placental artery, a significant treatment by dose interaction was observed 
when arterial rings were incubated with NLA. Regardless of maternal nutrition, relaxation was 
completely abolished (i.e. 100%) in the CC-NLA (P < 0.0001), RC-NLA (P < 0.0001), and RR-
NLA (P < 0.0001) arteries compared with CC-NI (Figure 3.5C), RC-NI (Figure 3.6C), and RR-
NI (Figure 3.7C) arteries.  
In the COT arteries incubated with NLA, pD2 value tended to be higher (P < 0.01) in the 
RC-NI (6.60 ± 0.31) arteries vs RC-NLA (8.13 ± 0.31) arteries while no differences were 
observed in the pD2 values in the CC (P = 0.29; 7.29 ± 0.36 vs 7.82 ± 0.29 for CC-NI and CC-
NLA, respectively) and RR (P = 0.15; 7.53 ± 0.19 vs 8.02 ± 0.24 for RR-NI and RR-NLA, 
respectively) cows. Moreover, the BK CRCs Emax value for COT arteries in the presence of NLA 
was significantly greater in the CC-NLA (P = 0.0001; 114.43 ± 8.75), RC-NLA (P < 0.0001; 
112.12 ± 5.38), and RR-NLA (P < 0.0001, 124.10 ± 5.18) arteries compared with CC-NI (21.09 
± 10.71), RC-NI (23.77 ± 5.38), and RR-NI (29.63 ± 5.18) arteries.  
Caruncular and Cotyledonary Arterial Responses to Bradykinin  
The CRCs comparing the effects of BK in the CAR and COT placental arteries had a 
significant treatment by dose interaction in the CC-CAR vs CC-COT (P = 0.006) (Figure 3.8A), 
RC-CAR vs RC-COT (P < 0.0001) (Figure 3.8B) and RR-CAR vs RR-COT (P < 0.0001) 
(Figure 3.8C) arteries. The CC-CAR, RR-CAR were  more sensitive to BK mediated 
vasodilation until the 3 × 10
-8
 M dose of BK and RC-CAR until 10
-7
 M dose of BK compared 
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with CC-COT, RR-COT, and RC-COT arteries. The CAR arteries reached a stable plateau at 
subsequent BK doses.  
In the COT placental arteries relaxation was initially delayed in the CC-COT, RC-COT, 
and RR-COT arteries. However, in the CC-COT arteries sensitivity to BK was enhanced at the 
last two doses compared with CC-CAR rings, while the RC-COT and RR-COT responded 
similarly to RC-CAR and RR-CAR arteries beginning at 3 × 10
-7
 M and 10
-7
 M dose of BK. 
Maternal nutrition influenced the pD2 values in the COT placental arteries. The CC-COT 
(P = 0.03; 7.29 ± 0.29), RC-COT (P < 0.0001; 6.60 ± 0.17), and RR-COT (P = 0.005; 7.53 ± 
0.28) had significantly higher pD2 values compared with CC-CAR (8.67 ± 0.33) RC-CAR (8.62 
± 0.17) and RR-CAR (8.98 ± 0.28) arteries. Further, in the CC-COT arteries, the Emax values (P = 
0.07) tended to be lower (21.09 ± 10.61) than the CC-CAR (51.59 ± 9.49) arteries while the BK 
response curves Emax values were not influenced in the RC (P = 0.62; 33.21 ± 12.98 vs 23.77 ± 
12.98 for RC-CAR and RC-COT, respectively) and RR (P = 0.87; 27.78 ± 7.59 vs 29.63 ± 7.59 
for RR-CAR and RR-COT, respectively) cows. 
BK2R mRNA Expression  
 Maternal dietary treatment did not influence the mRNA expression of BK2R in the CAR 
(P = 0.50; 1.31, 1.49, 1.52 ± 0.14 arbitrary units for CC, RC, and RR, respectively) and the COT 
(P = 0.58; 1.39, 1.22, 1.34 ± 0.12 arbitrary units for CC, RC, and RR, respectively) placental 
arteries.  
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Figure 3.1. The impacts of maternal nutrition and bradykinin (BK) dose on the BK 
concentration response curve in (A) caruncular (CAR) arteries and (B) cotyledonary (COT) 
arteries. Cows received 100% (CC) NRC requirements from d 30 to d 140, 60% (RC) NRC 
requirements from d 30 to d 85 with realimentation to 100% NRC requirements on d 85 until d 
140, and 60% (RR) NRC requirements from d 30 to d 140 of gestation. Figure compares BK 
concentration response curve obtained in the absence of any inhibitor (no inhibitor, NI) of each 
dietary treatment (CC vs RC vs RR). ^CC is statistically different from RR (P < 0.001). * RC is 
statistically different from CC (P = 0.008) and RR (P < 0.02). 
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Figure 3.2. The impacts of maternal nutrition and bradykinin (BK) dose on the BK concentration response curve in caruncular (CAR) 
arteries with no inhibitor (NI) compared with arteries (A) after incubation with icatibant acetate (HOE 140), (B) after incubation with 
iberiotoxin (IbTX), (C) after incubation with N(nitro)-L-arginine (NLA), and (D) after incubation with indomethacin (INDO). Cows 
received 100% (CC) NRC requirements from d 30 to d 140 of gestation. 
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Figure 3.3. The impacts of maternal nutrition and bradykinin (BK) dose on the BK concentration response curve in caruncular (CAR) 
arteries with no inhibitor (NI) compared with arteries (A) after incubation with icatibant acetate (HOE 140), (B) after incubation with 
iberiotoxin (IbTX), (C) after incubation with N(nitro)-L-arginine (NLA), and (D) after incubation with indomethacin (INDO). Cows 
received 60% (RC) NRC requirements from d 30 to d 85 with realimentation to 100% NRC requirements on d 85 until d 140 of 
gestation. 
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Figure 3.4. The impacts of maternal nutrition and bradykinin (BK) dose on the BK concentration response curve in caruncular (CAR) 
arteries with no inhibitor (NI) compared with arteries (A) after incubation with icatibant acetate (HOE 140), (B) after incubation with 
iberiotoxin (IbTX), (C) after incubation with N(nitro)-L-arginine (NLA), and (D) after incubation with indomethacin (INDO). Cows 
received 60% (RR) NRC requirements from d 30 to d 140 of gestation. 
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Figure 3.5. The impacts of maternal nutrition and bradykinin (BK) dose on the BK concentration response curve in cotyledonary 
(COT) arteries with no inhibitor (NI) compared with arteries (A) after incubation with icatibant acetate (HOE 140), (B) after 
incubation with iberiotoxin (IbTX), and (C) after incubation with N(nitro)-L-arginine (NLA). Cows received 100% (CC) NRC 
requirements from d 30 to d 140 of gestation. 
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Figure 3.6. The impacts of maternal nutrition and bradykinin (BK) dose on the BK concentration response curve in cotyledonary 
(COT) arteries with no inhibitor (NI) compared with arteries (A) after incubation with icatibant acetate (HOE 140), (B) after 
incubation with iberiotoxin (IbTX), and (C) after incubation with N(nitro)-L-arginine (NLA). Cows received 60% (RC) NRC 
requirements from d 30 to d 85 with realimentation to 100% NRC requirements on d 85 until d 140 of gestation. 
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Figure 3.7. The impacts of maternal nutrition and bradykinin (BK) dose on the BK concentration response curve in cotyledonary 
(COT) arteries with no inhibitor (NI) compared with arteries (A) after incubation with icatibant acetate (HOE 140), (B) after 
incubation with iberiotoxin (IbTX), and (C) after incubation with N(nitro)-L-arginine (NLA). Cows received 60% (RR) NRC 
requirements from d 30 to d 140 of gestation. 
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Figure 3.8. The impacts of maternal nutrition and bradykinin (BK) dose on the BK concentration response curve in the caruncular 
(CAR) and cotyledonary (COT) arteries without an inhibitor (NI) in cows receiving (A) 100% (CC) NRC requirements from d 30 to 
d 140 of gestation, (B) 60% (RC) NRC requirements from d 30 to d 85 with realimentation to 100% NRC requirements on d 85 until d 
140 of gestation, and (C) 60% (RR) NRC requirements from d 30 to d 140 of gestation. 
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Discussion 
While we observed a compensatory growth upon nutrient restriction during early 
gestation in both, the CAR and the COT portions of the placenta; it was interesting to note that at 
d 140 of gestation the two portions responded differently to restriction and restriction followed 
by realimentation. Global maternal nutrient restriction during early and mid-gestation (RR-NI; d 
30 to d 140) increases the sensitivity of the CAR placental arteries to vasorelaxation in response 
BK when compared with the cows receiving 100% nutrient requirements (CC-NI) and produces 
a tendency for increased vasorelaxation than cows receiving a restricted diet (d 30 to d 85) 
during early gestation followed by realimentation (RC, d 85 to d 140). Our findings reveal that 
maternal nutrient restricition for a longer duration (from d 30 to d 140) is beneficial as it 
promotes vasodilation in the CAR placental arteries. On the other hand, in the COT placental 
arteries, the CC-NI and the RR-NI cows responded similarly and showed increased sensitivity to 
BK compared with the RC-NI cows where relaxation was delayed. Similar responses observed in 
the COT placental arteries in the RR-NI and the CC-NI cows might be a result of the nutrient 
restriction during early gestation which helps sustain vasodilation through mid-gestation in the 
RR-NI cows bringing placental vasoactivity similar to CC-NI cows in response to BK; while 
realimentation does not seem to have a beneficial effect on BK induced vasodilation in the RC-
NI cows.  
A successful pregnancy in all mammals is energetically costly and marks a 20-50% 
increase in the maternal metabolic rate (Brody, 1938; Ferrell et al., 1976; Ferrell and Jenkins, 
1985; Robson et al., 1989; Stock and Metcalfe, 1994) primarily supporting the dramatic 
alterations in the maternal cardiovascular system and the utero-placental vascular bed (Rosenfeld 
and Fixler, 1977; Reynolds and Redmer, 1995; Magness, 1998) ensuring optimum fetal growth 
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and development (Reynolds and Redmer, 1995; Reynolds et al., 2010). The placenta undergoes a 
variety of physiological changes to adapt to the various environmental stressors to drive fetal 
programming. Intrauterine growth restriction which is often caused by maternal under-nutrition 
during gestation can lead to stunted placental and fetal growth and development (Barker, 1997). 
Therefore, the development of potential therapeutics aimed at enhancing placental efficiency to 
promote nutrient delivery to the fetus would potentially be beneficial in overcoming 
compromised pregnancies (Reynolds et al., 2006, 2010).    
 In order to investigate the pathway responsible for BK induced relaxation, the CAR and 
the COT placental arteries were incubated in the presence of various inhibitors. The results of the 
present study show that maternal nutrient restriction and restriction followed by realimentation 
influences vasorelaxation produced in response to BK; however, the mechanisms employed for 
mediating relaxation in the CAR and the COT placental arteries are different. The CAR placental 
arteries had a higher pD2 value in the presence of HOE 140 which delayed relaxation at lower 
doses but, failed to inhibit relaxation at the highest dose indicative of an adaptive response or 
perhaps, regulation of vasodilation via the BK1R in conjuction with BK2R in the CAR placental 
arteries. Whereas, in the COT placental arteries relaxation was abolished and arteries incubated 
with HOE 140 had a significantly higher Emax value implying that the vasodilatory effects of BK 
are solely exerted via the BK2R in the COT placental arteries. 
 Furthermore, BKCa channels are involved in mediating relaxation in the CAR arteries; 
while, no effect was observed in the COT arteries upon incubation with IbTX. In the current 
study, the COT placental arteries relaxed despite blocking the BKCa channels. Since, the 
EDHF(s) are representative of a diverse group of chemical compounds comprising of L-
citrulline, K
+
 ion, H2O2, anandamide, and epoxyeicosatrienoic acids (Tanaka et al., 2004), it is 
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quite possible that the observed relaxations are likely due to an EDHF that is not inhibited by 
IbTX in the COT arteries. As gestation advances, the placenta is required to keep pace with the 
ever increasing fetal demands for growth and development. Thus, relaxation produced in the 
COT placental arteries might be an adaptive response to ensure optimum nutrient delivery to the 
fetus. Therefore, further investigation of EDHF(s) is required which might provide a potential 
mechanism responsible for mediating BK induced relaxation in COT placental arteries in the 
presence of IbTX.  
In the presence of NLA, relaxation was inhibited in the CAR arteries and interestingly, 
Emax values of RC-NLA and RR-NLA arteries were significantly greater than RC-NI and RR-NI 
arteries suggesting that the role of NO is enhanced upon nutrient restriction and realimentation. 
Additional studies investigating the expression of eNOS across gestation would help explain the 
elevated role NO in the RC and the RR arteries. In the COT placental arteries relaxation was 
completely abolished and Emax values were greater in the presence of NLA which points out the 
pivotal role of NO in mediating vasodilation. The primary vasodilator is likely NO released from 
the endothelial cells in response to BK in the COT arteries.  
Maternal diet had no effect on the CAR CC arteries and the RC arteries in the presence of 
INDO; however, relaxation was inhibited in the RR arteries which had a greater Emax value. This 
could possibly be a compensatory mechanism in the CAR arteries induced as a result of a longer 
nutrient restriction in the RR arteries to ensure optimum nutrient delivery to the developing fetus.   
 Similar to our findings at d 85 of gestation (Reyaz, Chapter 2) the mRNA expression of 
the BK2R analyzed in the present study did not differ across the three treatment groups in both 
the CAR and the COT placental arteries, implying that while the receptor gene expression is not 
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altered by nutritional status, enhanced BK activity must be augmented downstream from the 
predominant receptor type. It remains unknown how BK1R may change due to nutritional 
adaptation which might be a stress induced response to overcome nutrient restriction in the CAR 
placental arteries. These findings further emphasize the importance of vasoreactivity assays and 
perhaps a combination of the BK1R and the BK2R receptor inhibitors would help in better 
understanding of the specific role played by each receptor type across gestation.  
 Lastly, in the CAR placental arteries it is of interest to note that maternal nutrient 
restriction during early gestation followed by realimentation (RC-CAR) and a longer period of 
restriction (RR-CAR) significantly enhances BK induced relaxation however, their Emax values 
are similar with the COT arteries. While this held true for the RC and RR arteries, this effect was 
not observed in the CC-CAR arteries which had a tendency for a greater Emax compared with 
CC-COT arteries. Overall, the COT placental arteries had a greater pD2 value suggesting that 
relaxation was delayed when compared with the CAR placental arteries. This is similar to our 
findings at d 85 of gestation; where we reported the CAR vascular bed to be more sensitive to 
BK induced vasodilation at lower doses of BK than the COT vascular bed. Since, early and mid-
gestation is critical time for placental-fetal growth and development the increased sensitivity 
could allow for an efficient nutrient delivery system to the fetus. 
Taken together, the results of the present study support our hypothesis that global 
maternal nutrient restriction or restriction followed by realimentation in pregnant beef cows 
alters sensitivity of the maternal and the fetal arteries to BK induced relaxation which is 
mediated by the BK2R and at least partly by the pathways mediating BK induced vasodilation in 
the placental arteries. Further investigations are required in the area of bovine maternal and fetal 
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placental development during late gestation and how potential therapeutics may impact 
compromised pregnancies in a cow.  
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CHAPTER 4. INFLUENCE OF MATERNAL NUTRIENT RESTRICTION DURING 
EARLY AND MID-GESTATION FOLLOWED BY REALIMENTATION ON 
PLACENTAL VASCULAR FUNCTION IN LATE PREGNANT BEEF COWS 
Abstract 
We hypothesize that global maternal nutrient restriction during early and mid-gestation 
followed by realimentation would alter the caruncular (CAR) and cotyledonary (COT) placental 
artery sensitivity to bradykinin (BK) induced relaxation. Further, we hypothesized that placental 
arterial vasodilation is mediated at least partly through the bradykinin 2 receptor (BK2R) and its 
pathways which may be impacted by the maternal diet. To examine the effects of maternal 
nutrient restriction and realimentation on CAR and COT artery vasoactivity during mid-
gestation, multiparous beef cows on d 30 of gestation were randomly assigned to receive 100% 
(d 30 to d 254) NRC requirements (CCC; n = 6), 60% (d 30 to d 85) followed by 100% (d 85 to 
d 254) NRC requirements (RCC; n = 5), and 60% (d 85 to d 140) followed by 100% (d 140 to d 
254) NRC requirements (RRC; n = 6). At d 254 of gestation cows were euthanized and arteries 
that terminated into the maternal (CAR artery) and fetal portions (COT artery) of the placentome 
were dissected to be used for in vitro vasoreactivity assays and mRNA expression. The 
endothelium-intact CAR arterial rings were loaded in an organ bath chamber and contracted with 
NE (10
-6
 M) and the concentration response curve (CRC) to BK was obtained. In addition, a BK 
CRC was obtained for rings which were incubated for 30 min with inhibitors to: 1) BK2R, 
icatibant acetate (HOE 140; 10
-6 
M); 2) large conductance Ca
2+ 
activated K
+
 channels, 
iberiotoxin (IbTX; 10
-7 
M); 3) endogenous nitric oxide synthase, N(nitro)-L-arginine, (NLA; 10
-5
 
M); and 4) prostacyclins (PGI2), indomethacin (INDO; 10
-5
 M). Additionally, endothelium-intact 
COT arterial rings were contracted with U46619 (10
-6
 M) and the effect of BK and the above 
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mentioned inhibitors were studied with the exception of PGI2. The CAR arterial rings with no 
inhibitor (NI) were not influenced by the maternal diet and arteries responded similarly (P = 
0.84) across treatments. Upon incubation with HOE 140, a treatment by dose interaction was 
observed in the RCC (P = 0.03) arteries while an effect of diet was observed in the CCC (P < 
0.002) and the RRC (P < 0.0001) arteries which delayed relaxation at lower doses; however, the 
CAR arteries responded similarly at higher doses indicating the presence of an alternate 
mechanism or regulation of vasodilation partly via the BK1R in conjunction with the BK2R 
type. An effect of dietary treatment was observed in the three treatment groups in the presence of 
IbTX which inhibited relaxation (P < 0.0001) suggesting that BKCa channels are involved in 
mediating relaxation in the CAR placental arteries. There was a treatment by dose interaction 
upon incubation with NLA in the RCC (P < 0.0001) and the RRC (P = 0.05) cows while an 
effect of diet was observed in the CCC (P < 0.0001) arteries which blocked relaxation. There 
was also an effect of maternal diet in the RCC (P < 0.001) and RRC (P < 0.01)  arteries in the 
presence of INDO which delayed relaxation at lower doses while no effect was observed in the 
arteries from CCC (P = 0.71) cows. The NI COT arterial rings were not influenced by the 
maternal diet and arteries responded similarly (P = 0.10) across treatments. A treatment by dose 
interaction was observed in the CCC (P = 0.002) and the RCC (P < 0.0001) arteries in the 
presence of HOE 140 and relaxation was inhibited while an effect of diet was observed in the 
RRC (P < 0.04) arteries. Inhibition of BKCa channels failed to attenuate (P > 0.19) the BK 
response across treatments, indicating that BKCa channels may not be involved in BK responses 
in COT arteries. There was a treatment by dose interaction and NLA blocked (P < 0.0008) BK 
induced relaxation in all treatments. The mRNA expression of BK2R was not altered (P ≥ 0.48) 
by the maternal diet during late gestation. It appears that placental arteries have completely 
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adapted after the two durations of nutrient restriction followed by realimentation and are 
responding similarly to the control arteries. Despite this, there may be different durations of 
restriction which may program the placenta to compensate for the loss of nutrients by 
vasodilation thorugh different BK mediated mechanisms.  
Key words: bradykinin, cow, placenta, vascular function 
Introduction 
By late gestation, the primary function of the placenta is to support the exponential 
growth of the fetus during the last half of gestation (Ferrell, 1989; Metcalfe, 1998; Reynolds and 
Redmer, 1995). Several models of underfed ewes during late gestation have found to hinder the 
fetal growth trajectory (Mellor, 1983; Robinson, 1983; Vincent et al., 1985; Parr et al., 1986) and 
transplacental exchanges. Limited studies investigating the effects of maternal nutrient restriction 
followed by realimentation in the bovine have reported an increase in the CAR tissue which 
might result in enhanced placental efficiency in the nutrient restricted cows (Vonnahme et al., 
2007; Zhu et al., 2007). 
While we observed a compensatory growth upon nutrient restriction during early 
gestation (d 85) in both, the caruncular (CAR) and the cotyledonary (COT) portions of the 
placenta; it was interesting to note that at d 140 of gestation the two portions responded 
differently to restriction and restriction followed by realimentation. In order to further investigate 
the effect of dietary treatment during late gestation, vasoactivity assays were performed on 
placental arteries. We hypothesized that global maternal nutrient restriction during early and 
mid-gestation followed by realimentation in pregnant beef cows would alter placental arterial 
vascular function due to changes in placental arterial sensitivity to BK. Further, we also 
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hypothesized that placental arterial vasodilation is mediated at least partly through the BK2R and 
that global maternal nutrient restriction may impact the pathways mediating BK induced 
vasodilation in the placental arteries. Thus, the objective of this study was to examine the effects 
of global maternal nutrient restriction during early and mid-gestation followed by realimentation 
on the mechanisms of BK induced vasorelaxation in the placental arteries of cow. 
Materials and Methods 
 All procedures involving animals were approved by the North Dakota State University 
(NDSU) Animal Care and Use Committee (#A10001).  
Animals, Diets, and Breeding  
Animal breeding was similar as described in chapter 2; however, the durations of the 
applied dietary treatments were different. On d 30 of gestation multiparous beef cows were 
randomly assigned to receive 100% (d 30 to d 254) NRC requirements (CCC; n = 6), 60% (d 30 
to d 85) followed by 100% (d 85 to d 254) NRC requirements (RCC; n = 5), and 60% (d 85 to d 
140) followed by 100% (d 140 to d 254) NRC requirements (RRC; n = 6). At d 254 of gestation 
cows were euthanized and arteries terminating into the maternal (caruncular, CAR) and the fetal 
(cotyledonary, COT) portions the placentome were dissected to be used for in vitro 
vasoreactivity assays and mRNA expression. 
Tissue collection, experimental drug preparations, organ chamber studies, receptor 
quantification and data analysis methods are same as described in chapter 2.   
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Results 
Caruncular Arterial Responses  
In the CAR arteries there was no interaction (P = 0.81) neither an effect of treatment (P = 
0.84) was observed on the BK CRCs with no inhibitor (NI) (Figure 4.1A). There was an effect of 
dose (P < 0.0001) where CCC-NI, RCC-NI, and RRC-NI arteries responded similarly to BK. 
Maternal diet neither had a impact on the pD2 values (P = 0.52; 8.48 ± 0.37 vs 8.81 ± 0.37 vs 
9.05 ± 0.33 for CCC-NI, RCC-NI, and RRC-NI respectively) nor the Emax values (P = 0.97; 
38.33 ± 12.76 vs 41.06 ± 13.98 vs 42.53 ± 13.98 for CCC-NI, RCC-NI, and RRC-NI 
respectively) for BK CRCs in CAR arteries with NI.  
The CCC-NI vs CCC-HOE 140 arteries did not have a significant (P = 0.99) treatment by 
dose interaction in the presence of HOE 140 but, an effect of maternal nutrition (P = 0.002) was 
observed (Figure 4.2A). The arteries depicted a similar pattern of relaxation which was not 
inhibited upon incubation with HOE 140. The BK dose response curves in the presence of HOE 
140 had a significant (P = 0.03) treatment by dose interaction in RCC-NI vs RCC-HOE 140 
arteries (Figure 4.3A). Arterial rings responded similarly until the 10
-9
 M dose of BK. Beginning 
at 3 × 10
-9
 M dose, RCC-NI arterial rings were more sensitive to vasodilation until 10
-6
 M dose 
of BK while relaxation was delayed in RCC-HOE 140 rings. However, at the highest doses of 
BK (3 × 10
-6
 M) RCC-NI and RCC-HOE 140 arteries responded similarly to BK. In the RRC-NI 
vs RRC-HOE 140 arteries there was no treatment by dose interaction (P = 0.71) upon incubation 
with HOE 140. An overall effect of maternal nutrition (P < 0.0001) was observed which delayed 
BK mediated vasodilation in the RRC-HOE 140 vs RRC-NI arteries (Figure 4.4A); however, at 
the highest dose (3 × 10
-6
 M) of BK the arteries responded similarly.     
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In the CAR placental arteries incubated with HOE 140 the pD2 values were higher (P = 
0.02) in the RRC-HOE 140 (7.05 ± 0.48) arteries vs RRC-NI (9.05 ± 0.48) arteries. Maternal diet 
did not impact the pD2 values in the CCC (P = 0.48; 8.46 ± 0.59 vs 7.78 ± 0.68 for CCC-NI and 
CCC-HOE 140, respectively) and RCC cows (P = 0.79; 8.81 ± 0.29 vs 8.92 ± 0.29 for RCC-NI 
and RCC-HOE 140, respectively). Further, the Emax values of the BK CRCs with HOE 140 were 
not influenced by the maternal diet in the CCC (P = 0.56; 38.33 ± 10.90 vs 48.24 ± 12.04 for 
CCC-NI and CCC-HOE 140, respectively), RCC (P = 0.64; 41.06 ± 11.51 vs 49.46 ± 12.87 for 
RCC-NI and RCC-HOE 140, respectively), and RRC (P = 0.82; 42.53 ± 11.82 vs 46.55 ± 11.82 
for RRC-NI and RRC-HOE 140, respectively) arteries for HOE 140. 
In the CAR placental arteries incubated with IbTX, a tendency for a treatment by dose 
interaction (P = 0.06) was observed in the RCC arteries and an effect of maternal diet was 
observed in the CCC-IbTX (P < 0.0001), RCC-IbTX (P < 0.0001), and RRC-IbTX (P < 0.0001) 
arteries which inhibited relaxation compared with CCC-NI (Figure 4.2B), RCC-NI (Figure 
4.3B), and RRC-NI (Figure 4.4B) arteries.  
The BK CRCs pD2 values for CAR placental arteries with IbTX tended to be higher (P = 
0.06) in the RRC- IbTX (7.36 ± 0.59) arteries compared with RRC-NI (9.05 ± 0.46) arteries 
while no effect of maternal diet was observed in the CCC (P = 0.74; 8.48 ± 0.59 vs 8.12 ± 0.83 
for CCC-NI and CCC-IbTX, respectively) and the RCC (P = 0.10; 8.81 ± 0.23 vs 7.59 ± 0.47 for 
RCC-NI and RCC-IbTX, respectively) arteries. In the CAR arteries incubated with IbTX, CCC-
IbTX (P < 0.01; 96.22 ± 13.11) and RRC-IbTX (P = 0.01; 96.94 ± 11.60) arteries had a greater 
Emax value compared with CCC-NI (38.33 ± 10.70) and RRC-NI (42.53 ± 11.60) arteries while 
RCC-IbTX (P = 0.08; 85.18 ± 16.07) arteries had a tendency for a greater Emax value than the 
RCC-NI (41.06 ± 14.37) arteries. 
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The CAR placental arteries treated with NLA had a significant treatment by dose 
interaction which blocked relaxation however, this effect was only observed in the RCC-NLA (P 
< 0.0001) and RRC-NLA (P = 0.05) arteries vs RCC-NI (Figure 4.3C) and RRC-NLA (Figure 
4.4C) arteries. In the CCC-NLA vs CCC-NI arteries, the treatment by dose interaction was not 
significant (P = 0.83) but, an effect of dietary treatment (P < 0.0001) was observed (Figure 4.2C) 
which inhibited BK mediated relaxation in the presence of NLA.   
The pD2 values in CAR arteries incubated with NLA were not influenced (P = 0.59; 8.48 
± 0.56 vs 8.07 ± 0.46 for CCC-NI and CCC-NLA, respectively; P = 0.18; 8.81 ± 0.39 vs 7.71 ± 
0.55 for RCC-NI and RCC-NLA, respectively; P = 0.18; 9.05 ± 0.57 vs 7.94 ± 0.52 for RRC-NI 
and RRC-NLA, respectively) by the maternal dietary treatment. The Emax of the BK CRCs 
incubated with NLA was greater than the arteries with NI (P < 0.01; 38.33 ± 10.83 vs 88.42 ± 
10.83 for CCC-NI and CCC-NLA, respectively; P < 0.01; 41.06 ± 11.47 vs 105.85 ± 12.83 for 
RCC-NI and RCC-NLA, respectively; P < 0.003; 42.53 ± 9.04 vs 93.00 ± 8.25 for RRC-NI and 
RRC-NLA, respectively).  
 For CAR placental arteries incubated with INDO, neither the treatment by dose 
interaction (P = 0.98) nor an effect of dietary treatment (P = 0.71) was significant in CCC-INDO 
vs CCC-NI arteries (Figure 4.2D) and relaxation was not inhibited upon incubation with INDO. 
The treatment by dose interaction was not significant however, an effect of treatment was 
observed in RCC (P = 0.001) and RRC (P = 0.01) arteries. The RCC-NI and RCC-INDO (Figure 
4.3D) arteries responded similarly until 3 × 10
-9
 M dose of BK. Beginning at the 10
-8
 M dose, 
relaxation was delayed in RCC-INDO arteries however, at the last dose (3 × 10
-6
 M) of BK, 
arteries responded similarly. Similar patterns of relaxation were observed in the RRC-INDO 
arteries vs the RRC-NI arteries (Figure 4.4D). 
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 In the CAR arteries incubated with INDO, the pD2 values were similar (P = 0.38; 8.48 ± 
0.47 vs 9.11 ± 0.47 for CCC-NI and CCC-INDO, respectively; P = 0.14; 8.80 ± 0.55 vs 7.48 ± 
0.55 for RCC-NI and RCC-INDO, respectively; P = 0.33; 9.05 ± 0.37 vs 8.50 ± 0.37 for RRC-NI 
and RRC-INDO, respectively) across the three treatment groups. Moreover, no differences were 
observed on the Emax BK CRCs (P = 0.62; 38.33 ± 12.75 vs 48.04 ± 13.96 for CCC-NI and CCC-
INDO, respectively; P = 0.97; 41.06 ± 12.62 vs 40.29 ± 14.11 for RCC-NI and RCC-INDO, 
respectively; P = 0.85; 42.53 ± 12.62 vs 46.08 ± 12.62 for RRC-NI and RRC-INDO, 
respectively) in the CAR placental arteries.  
Cotyledonary Arterial Responses  
In the COT placental arteries neither the treatment by dose interaction (P = 0.99) nor an 
effect of dietary treatment (P = 0.10) was significant on the BK CRCs with NI (Figure 4.1B). 
There was an effect of dose (P < 0.0001) and CCC-NI, RCC-NI, and RRC-NI arteries responded 
similarly to BK. Maternal diet did not impact the pD2 values (P = 0.31; 6.54 ± 0.72 vs 6.19 ± 
0.24 vs 6.71 ± 0.56 for CCC-NI, RCC-NI and RRC-NI respectively) and the Emax values (P = 
0.82; 53.67 ± 7.78 vs 53.69 ± 8.70 vs 59.17 ± 7.78 for CCC-NI, RCC-NI, and RRC-NI 
respectively) for BK CRCs in CAR arteries with NI.  
The COT placental artery rings incubated with HOE 140 had a significant treatment by 
dose interaction in the CCC (P = 0.002) (Figure 4.5A) and RCC (P < 0.0001) (Figure 4.6A) 
arteries. The CCC-HOE 140 and RCC-HOE 140 aretries responded similarly to CCC-NI and 
RCC-NI arteries until 10
-7 
M and 3 ×10
-7 
M dose of BK after which relaxation was inhibited at 
susbsequent BK doses. In the RRC cows the treatment by dose interaction was not significant (P 
= 0.59); however, an effect of treatment (P = 0.04) was observed. The RRC-NI and RRC-HOE 
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140 arteries responded similarly to BK until the 3 ×10
-7 
M dose, after which relaxation was 
delayed in the RRC-HOE 140 arteries (Figure 4.7A).  
In the COT placental arteries incubated with HOE 140, the pD2 values were similar (P = 
0.88; 6.54 ± 0.47 vs 6.48 ± 0.33 for CCC-NI and CCC-HOE 140, respectively; P = 0.25; 6.19 ± 
0.71 vs 7.48 ± 0.71 for RCC-NI and RCC-HOE 140, respectively; P = 0.92; 6.71 ± 0.32 vs 6.75 
± 0.29 for RRC-NI and RRC-HOE 140, respectively) to arteries with NI. An effect of dietary 
treatment was observed on the Emax values in the presence of HOE 140 in the CCC and the RCC 
arteries. The CCC-HOE 140 (P = 0.03; 80.72 ± 7.3) and RCC-HOE 140 (P < 0.01; 88.02 ± 6.23) 
arteries had a greater Emax value compared with CCC-NI (52.67 ± 7.99) and RCC-NI (53.69 ± 
6.23) arteries while the Emax BK CRCs for RRC cows were not different (P = 0.32; 59.17 ± 7.99 
vs 70.39 ± 7.29 for RRC-NI and RRC-HOE 140, respectively).  
The BK CRCs in the presence of IbTX had a significant treatment by dose interaction (P 
= 0.01); however this effect was only observed in the RCC-NI vs RCC-IbTX arteries (Figure 
4.6B). In the CCC and the RRC arteries neither the treatment by dose interaction (P ≥ 0.82) nor 
an effect of dietary treatment (P ≥ 0.35) was significant. There was an effect of dose (P < 
0.0001) and CCC-NI and RRC-NI arteries responded similarly to CCC-IbTX (Figure 4.5B) and 
RRC-IbTX (Figure 4.7B) arteries. 
The BK CRCs pD2 values for COT arteries with NI and COT arteries incubated with 
IbTX were similar (P = 0.96; 6.54 ± 0.10 vs 6.55 ± 0.09 for CCC-NI and CCC-IbTX, 
respectively; P = 0.81; 6.19 ± 0.18 vs 6.25 ± 0.16 for RCC-NI and RCC-IbTX, respectively; P = 
0.72; 6.71 ± 0.41 vs 6.91 ± 0.38 for RRC-NI and RRC-IbTX, respectively). The COT artery 
rings Emax values in the presence of IbTX were not influenced by the maternal diet in CCC (P = 
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0.44; 52.67 ± 10.94 vs 65.29 ± 10.94 for CCC-NI and CCC-IbTX, respectively), RCC (P = 0.11; 
53.69 ± 6.53 vs 69.97 ± 5.84 for RCC-NI and RCC-IbTX, respectively), and RRC (P = 0.82; 
59.17 ± 6.14 vs 61.09 ± 5.61 for RRC-NI and RRC-IbTX, respectively) cows.  
Upon incubation with NLA, a significant treatment by dose interaction was observed in 
CCC-NLA (P = 0.0006), RCC-NLA (P < 0.0001), and RRC-NLA (P = 0.0008) arteries 
compared with CCC-NI (Figure 4.5C), RCC-NI (Figure 4.6C), and RRC-NI (Figure 4.7C) 
arteries. The COT arteries from all cows responded similarly to BK until the 10
-7 
M dose of BK, 
after which the arteries with NI were more sensitive to BK while relaxation was inhibited in the 
NLA incubated arteries.  
In the COT placental arteries incubated with NLA, pD2 values were not affected by the 
maternal diet (P = 0.47; 6.54 ± 0.16 vs 6.38 ± 0.14 for CCC-NI and CCC-NLA, respectively; P = 
0.80; 6.19 ± 0.25 vs 6.09 ± 0.29 for RCC-NI and RCC-NLA, respectively; P = 0.80; 6.19 ± 0.25 
vs 6.09 ± 0.29 for RRC-NI and RRC-NLA, respectively). However, the BK dose response Emax 
value for COT arteries in the presence of NLA was significantly greater in the CCC-NLA (P = 
0.01; 88.49 ± 7.92), RCC-NLA (P < 0.01; 87.16 ± 6.52), and RRC-NLA (P < 0.01, 85.09 ± 5.44) 
arteries compared with CCC-NI (52.67 ± 7.92), RCC-NI (53.69 ± 7.29), and RRC-NI (59.17 ± 
5.44) arteries.  
Caruncular and Cotyledonary Arterial Responses to Bradykinin  
The CRCs comparing the vasodilatory effects of BK in the CAR and COT placental 
arteries had a significant treatment by dose interaction in the RCC-CAR vs RCC-COT (P < 
0.0001) (Figure 4.8B) and RRC-CAR vs RRC-COT (P < 0.03) (Figure 4.8C) arteries while a 
treatment effect (P < 0.0001) was observed when CCC-CAR arteries when compared with CCC-
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COT arteries (Figure 4.8A). The CAR placental arteries were more sensitive to BK induced 
vasodilation while, in the COT placental arteries, relaxation was initially inhibited and arteries 
reached a stable plateau until the 3 × 10
-8
 M dose of BK; after which sentivity was enhanced at 
the subsequent BK doses. The COT arteries responded similarly to the CAR arteries at the 
highest dose (3 × 10
-6
 M) of BK. 
Maternal nutrition influenced the pD2 values in the COT placental arteries. The CCC-
COT (P < 0.02; 6.54 ± 0.42), RCC-COT (P < 0.0001; 6.19 ± 0.19), and RRC-COT (P < 0.001; 
6.71 ± 0.31) had significantly higher pD2 values compared with CCC-CAR (8.48 ± 0.36), RCC-
CAR (8.81 ± 0.19), and RRC-CAR (9.05 ± 0.31) arteries. However, the Emax values for the CAR 
and COT placental arteries were similar (P = 0.43; 38.33 ± 11.66 vs 52.67 ± 12.77 for CCC-
CAR and CCC-COT, respectively; P = 0.49; 41.06 ± 11.78 vs 53.69 ± 13.17 for RCC-CAR and 
RCC-COT, respectively; P = 0.26; 42.53 ± 9.78 vs 59.17 ± 9.78 for RRC-CAR and RRC-COT, 
respectively) across treatments. 
BK2R mRNA Expression  
 Maternal dietary treatment did not significantly influence the mRNA expression of BK2R 
in the CAR (P = 0.48; 1.38, 1.33, 1.51 ± 0.11 arbitrary units for CCC, RCC, and RRC, 
respectively) and the COT (P = 0.73; 1.21, 1.36, 1.21 ± 0.16 arbitrary units for CCC, RCC and 
RRC, respectively) placental arteries.   
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Figure 4.1. The impacts of maternal nutrition and bradykinin (BK) dose on the BK 
concentration response curve in (A) caruncular (CAR) arteries and (B) cotyledonary (COT) 
arteries. Cows received 100% (CCC) NRC requirements from d 30 to d 254, 60% (RCC) NRC 
requirements from d 30 to d 85 with realimentation to 100 % NRC requirements on d 85 until d 
254, and 60% (RRC) NRC requirements from d 30 to d 140 with realimentation to 100% NRC 
requirements on d 140 until d 254 of gestation. Figure compares BK concentration response 
curve obtained in the absence of any inhibitor (NI) (CCC-NI vs RCC-NI vs RRC-NI).  
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Figure 4.2. The impacts of maternal nutrition and bradykinin (BK) dose on the BK concentration response curve in caruncular (CAR) 
arteries with no inhibitor (NI) compared with arteries (A) after incubation with icatibant acetate (HOE 140), (B) after incubation with 
iberiotoxin (IbTX), (C) after incubation with N(nitro)-L-arginine (NLA), and (D) after incubation with indomethacin (INDO). Cows 
received 100% (CCC) NRC requirements from d 30 to d 254 of gestation. 
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Figure 4.3. The impacts of maternal nutrition and bradykinin (BK) dose on the BK concentration response curve in caruncular (CAR) 
arteries with no inhibitor (NI) compared with arteries (A) after incubation with icatibant acetate (HOE 140), (B) after incubation with 
iberiotoxin (IbTX), (C) after incubation with N(nitro)-L-arginine (NLA), and (D) after incubation with indomethacin (INDO). Cows 
received 60% (RCC) NRC requirements from d 30 to d 85 with realimentation to 100% NRC requirements on d 85 until d 254 of 
gestation. 
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Figure 4.4. The impacts of maternal nutrition and bradykinin (BK) dose on the BK concentration response curve in caruncular (CAR) 
arteries with no inhibitor (NI) compared with arteries (A) after incubation with icatibant acetate (HOE 140), (B) after incubation with 
iberiotoxin (IbTX), (C) after incubation with N(nitro)-L-arginine (NLA), and (D) after incubation with indomethacin (INDO). Cows 
received 60% (RRC) NRC requirements from d 30 to d 140 with realimentation to 100% NRC requirements on d 140 until d 254 of 
gestation. 
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Figure 4.5. The impacts of maternal nutrition and bradykinin (BK) dose on the BK concentration response curve in cotyledonary 
(COT) arteries with no inhibitor (NI) compared with arteries (A) after incubation with icatibant acetate (HOE 140), (B) after 
incubation with iberiotoxin (IbTX), and (C) after incubation with N(nitro)-L-arginine (NLA). Cows received 100% (CCC) NRC 
requirements from d 30 to d 254 of gestation. 
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Figure 4.6. The impacts of maternal nutrition and bradykinin (BK) dose on the BK concentration response curve in cotyledonary 
(COT) arteries with no inhibitor (NI) compared with arteries (A) after incubation with icatibant acetate (HOE 140), (B) after 
incubation with iberiotoxin (IbTX), and (C) after incubation with N(nitro)-L-arginine (NLA). Cows received 60% (RCC) NRC 
requirements from d 30 to d 85 with realimentation to 100% NRC requirements on d 85 until d 254 of gestation. 
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Figure 4.7. The impacts of maternal nutrition and bradykinin (BK) dose on the BK concentration response curve in cotyledonary 
(COT) arteries with no inhibitor (NI) compared with arteries (A) after incubation with icatibant acetate (HOE 140), (B) after 
incubation with iberiotoxin (IbTX), and (C) after incubation with N(nitro)-L-arginine (NLA). Cows received 60% (RRC) NRC 
requirements from d 30 to d 140 with realimentation to 100% NRC requirements on d 140 until d 254 of gestation. 
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Figure 4.8. The impacts of maternal nutrition and bradykinin (BK) dose on the BK concentration response curve in the caruncular 
(CAR) and cotyledonary (COT) arteries without an inhibitor (NI) in cows receiving (A) 100% (CCC) NRC requirements from d 30 
to d 254 of gestation, (B) 60% (RCC) NRC requirements from d 30 to d 85 with realimentation to 100% NRC requirements on d 85 
until d 254 of gestation, and (C) 60% (RRC) NRC requirements from d 30 to d 140 with realimentation to 100% NRC requirements 
on d 140 until d 254 of gestation. 
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Discussion 
As described previously, maternal nutrient restriction during early (d 30 to d 85; Chapter 
2) and mid-gestation (d 30 to d 140; Chapter 3) increased the sensitivity of the CAR and the 
COT placental arteries to vasorelaxation in response to the endothelium dependent vasodilator, 
BK. These findings represent an important underlying mechanism by which dietary treatment 
may impact placental vasoactivity altering nutrient availability to the developing calf. This 
possibly depicts the presence of a compensatory mechanism employed by the placenta to ensure 
optimum nutrient delivery to the fetus induced as a result of maternal nutrient restriction during 
early and mid-gestation. However, during late gestation maternal diet had no effect on placental 
vasoactivity, and nutrient restriction followed by realimentation did not produce any changes in 
the CAR and the COT placental arteries which responded similarly across treatments. It is of 
interest to note that near term, the placental arteries have completely adapted after the two 
durations of nutrient restriction followed by realimentation and are responding similarly to the 
control arteries. Moreover, the mechanisms employed for mediating relaxation in the CAR and 
COT placental arteries are different. The CAR placental arteries had delayed relaxation at lower 
doses of BK in the presence of HOE 140; however, at the highest dose the arteries responded 
similarly indicative of an adaptive response or perhaps regulation of vasodilation via the BK1R 
inconjuction with the BK2R. In the COT placental arteries, incubation with HOE 140 yielded a 
higher Emax value in the CCC and the RCC cows suggesting an elevation in the role of the BK2R. 
While, relaxation was delayed in the RRC arteries at lower doses, no differences in Emax values 
were observed indicative of an alternate mechanism working in conjunction with the BK2R for 
mediating vasodilation in RRC cows.  
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Furthermore, BKCa channels are involved in mediating relaxation in the CAR arteries; 
while, no effect was observed in the COT arteries upon incubation with IbTX. In the current 
study, the COT placental arteries relaxed despite blocking the BKCa channels. Since, the 
EDHF(s) are representative of a diverse group of chemical compounds comprising of L-
citrulline, K
+
 ion, H2O2, anandamide, and epoxyeicosatrienoic acids (Tanaka et al., 2004), it is 
quite possible that the observed relaxations are likely due to an EDHF that is not inhibited by 
IbTX. As gestation advances, the placenta is required to keep pace with the ever increasing fetal 
demands for growth and development. Thus, relaxation produced in the COT placental arteries 
might be an adaptive response to ensure optimum nutrient delivery to the fetus. Therefore, 
further investigation of EDHF(s) is required which might provide a potential mechanism 
responsible for mediating BK induced relaxation in COT placental arteries in the presence of 
IbTX.  
In the presence of NLA, relaxation was inhibited in both, the CAR and the COT arteries 
pointing out the pivotal role of NO in mediating vasodilation in the placental arteries. The Emax 
value of the CAR and the COT placental arteries incubated with NLA were significantly greater 
implying that the primary vasodilator is likely NO released from the endothelial cells in response 
to BK.  
In the CAR placental arteries, in presence of INDO, although relaxation was inhibited in 
the RCC and the RRC arteries at a few doses of BK; the pD2 and Emax were values were similar 
across treatments indicating that INDO does not prevent the BK induced vasorelaxation in the 
CAR placental arteries, and perhaps BK does not elicit vasorelaxation through the PGI2 pathway 
in the CAR placental arteries.   
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The mRNA expression of the BK2R analyzed in the present study did not differ across 
the three treatment groups in both the CAR and the COT placental arteries, implying that the 
receptor gene expression is not altered by nutritional status. It remains unknown how BK1R may 
change due to nutritional adaptation which might be a stress induced response to overcome 
nutrient restriction in the CAR placental arteries. These findings further emphasize the 
importance of vasoreactivity assays rather than relying on mRNA expression data as the sole 
determinant. 
Lastly, it is of interest to note that maternal nutrient restriction during early and mid-
gestation followed by realimentation significantly enhances BK induced relaxation in the CAR 
placental arteries at lower doses. Overall, the COT placental arteries had a greater pD2 value 
suggesting that relaxation is delayed when compared with the CAR placental arteries. Similar to 
our findings at d 85 and d 140 of gestation, the CAR vascular bed is observed to be more 
sensitive to vasodilation at lower doses of BK than the COT vascular bed near term. This 
increased sensitivity could allow for an efficient nutrient delivery system and help support the 
exponential growth of the fetus during the last half of gestation (Metcalfe, 1988; Ferrell, 1989; 
Reynolds and Redmer, 1995). 
Taken together, the results of the present study do not support our hypothesis that global 
maternal nutrient restriction followed by realimentation in pregnant beef cows alters sensitivity 
of the maternal and the fetal arteries to BK induced relaxation. It appears that placental arteries 
have completely adapted after the two durations of nutrient restriction followed by 
realimentation and are responding similarly to the control arateries. Despite this, there may be 
different durations of restriction which may program the placenta to compensate vasodilation by 
different mechanisms. Although, relaxation is not influenced by the dietary treatment across 
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treatments it is mediated at least partly by the BK2R and its pathways mediating BK induced 
vasodilation in the placental arteries. Future investigations are required in the area of bovine 
maternal and fetal placental development and how potential therapeutics may impact 
compromised pregnancies in a cow. 
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CHAPTER 5. GENERAL CONCLUSIONS AND FUTURE DIRECTIONS 
General Conclusion 
There are currently very limited studies investigating the effects of global maternal 
nutrient restriction and realimentation on placental vascular function in the bovine. The current 
study is novel as it not only focuses on the effects of maternal nutrient restriction but also 
realimentation across gestation. While, early and mid-gestation are crucial times for placental 
establishment and growth, late gestation is marked by maximal fetal growth. Since, the placenta 
plays a pivotal role in developmental programming; any insults to the maternal system have the 
capacity of altering placental function (Barker, 1997). Inadequate placental function could lead 
to intrauterine growth restriction (IUGR) (Chandler et al., 1985; Barker et al., 1990; Barker et al., 
1993; Wallace et al., 2002; Carr et al., 2012; Lemley et al., 2012) resulting in life-long alterations 
in the postnatal life (Godfrey and Barker, 2000). Therefore, an understanding of factors that 
impact the placental vascular development and function with relation to utero-placental blood 
flow would influence the nutritional and physiological status of the offspring both, in utero and 
in postnatal life.  
Our findings suggest that a period of nutrient restriction during early and mid-gestation 
does not prove to be detrimental as it alters the vascular function of the placental arteries in the 
cow. The restricted animals are able to overcome the loss of nutrients via placental compensation 
while realimentation returns placental arteries vasoactivity similar to control cows in response to 
BK.  
 There are currently no good therapeutics for IUGR, and this is mainly due to a lack of 
knowledge on the mechanisms of IUGR. The results from this study provided novel information 
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which would help in the development of potential therapeutics aimed at enhancing placental 
efficiency which would potentially be beneficial in overcoming compromised pregnancies 
(Reynolds et al., 2006, 2010).    
  Overall, these studies indicate that global maternal nutrient restriction during early and 
mid-gestation likely plays a key role in the function of the placental vascular system.  Further, 
the maternal and fetal placental vascular beds should be viewed as two separate systems since 
the vasodilatory mechanisms in the arteries are likely mediated through different pathways.  
Future Directions 
 The data in this study contributes to the small number of studies regarding global 
maternal nutrient restriction and realimentation during gestation on placental vascular function in 
the cow. However, an important question to consider is if these alterations to the health of the 
offspring, placenta, and placental blood flow are due to an overall caloric restriction or due to 
restriction of a specific component in the diet. Since, variable levels of dietary protein have been 
shown to have an effect on various components of the placenta (Perry et al., 1999; Sullivan et al., 
2009); therefore, future studies investigating the role of different levels of dietary protein on 
placental vascular reactivity across gestation are important.  
 The current study also provides novel information on how BK induced vasodilation is 
mediated in the placental arteries. Given this information, future studies should be designed to 
better pinpoint the mechanism involved. For example, rather than incubating arterial rings with 
only one inhibitor, combinations of two or more inhibitors should be used to exactly detect how 
big of a role each of the endothelium-dependent pathways has in placental vasorelaxation and 
whether these pathways are inter-related. Since in the present study the effects of bradykinin 1 
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receptor (BK1R) were not analyzed, additional vasoactivity studies investigating the role of the 
BK1R and perhaps a combination of the BK1R and the bradykinin 2 receptor inhibitors which 
would help in the better understanding of the specific role played by each receptor type across 
gestation.  
  The fetal placental arteries relaxed in the presence of inhibitor to large conductance Ca
2+ 
activated K
+
 channels. Thus, further investigation of endothelial-derived hyperpolarizing is 
required to provide a potential BK induced vasodilatory mechanism in the fetal placental arteries. 
The effects of prostacyclins should be tested in the fetal placental arteries since; there was 
limited space in the wire myograph in the current study.  
Additionally, analysis of mRNA and protein expression of the BK1R, endothelial nitric 
oxide synthase and its receptor, soluble guanylate cyclase, could help answer some questions 
from the present study. Finally, similar studies to better understand the mechanisms of BK 
induced vasodilation in the placental arteries are needed if future therapeutics for compromised 
pregnancies will target the placental vascular beds. 
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